1
|
Hamano J, Takeuchi A, Mori M, Saitou Y, Yamaguchi T, Miyata N, Shimizu M, Yamamoto R, Kimura Y, Kamiyama Y, Arai Y, Matsuo H, Shishido H, Nakano K, Nishi T, Nagaoka H, Yokomichi N, Maeda I, Yamaguchi T, Morita T, Shinjo T. Comparison of survival times of advanced cancer patients with palliative care at home and in hospital. PLoS One 2023; 18:e0284147. [PMID: 37053183 PMCID: PMC10101528 DOI: 10.1371/journal.pone.0284147] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/28/2022] [Accepted: 03/27/2023] [Indexed: 04/14/2023] Open
Abstract
OBJECTIVES One primary concern about receiving care at home is that survival might be shortened because the quality and quantity of treatment provided at home will be inferior to that given in the hospital. Although our previous study demonstrated a longer survival of those with home-based palliative care (PC), it lacked adjustment for some potential confounders including symptoms and treatments during the stay. We aimed to compare the survival times among advanced cancer patients receiving home-based and hospital-based PC with adjusting for symptoms and treatments. METHOD We compared survival time of participants who enrolled two multicenter, prospective cohort studies of advanced cancer patients at 45-home-based PC services between July 2017 and December 2017, and at 23-hospital-based PC services between January 2017 and December 2017. We analyzed with stratification by the estimated survival of Days, Weeks, and Months, which were defined by modified Prognosis in Palliative care Study predictor models-A. We conducted a Cox regression analysis with adjusting for potential confounders including symptoms and treatments during the stay. RESULTS A total of 2,998 patients were enrolled in both studies and 2,878 patients were analyzed; 988 patients receiving home-based PC and 1,890 receiving hospital-based PC. The survival time of patients receiving home-based PC was significantly longer than that of patients receiving hospital-based PC for the Days Prognosis (estimated median survival time: 10 days [95% CI 8.1-11.8] vs. 9 days [95% CI 8.3-10.4], p = 0.157), the Weeks prognosis (32 days [95% CI 28.9-35.4] vs. 22 days [95% CI 20.3-22.9], p < 0.001), and the Months Prognosis, (65 days [95% CI 58.2-73.2] vs. 32 days [95% CI 28.9-35.4], p < 0.001). CONCLUSION In this cohort of advanced cancer patients with a Weeks or Months prognosis, those receiving home-based PC survived longer than those receiving hospital-based PC after adjusting for symptoms and treatments.
Collapse
Affiliation(s)
- Jun Hamano
- Faculty of Medicine, Department of Palliative and Supportive Care, University of Tsukuba, Tsukuba, Japan
| | - Ayano Takeuchi
- Department of Preventive Medicine and Public Health, School of Medicine, Keio University, Tokyo, Japan
| | - Masanori Mori
- Division of Palliative and Supportive Care, Seirei Mikatahara General Hospital, Hamamatsu, Japan
| | | | | | | | | | - Ryo Yamamoto
- Saku Central Hospital Advanced Care Center, Saku-shi, Nagano, Japan
| | | | | | | | | | | | | | - Tomohiro Nishi
- Kawasaki Municipal Ida Hospital, Kawasaki, Kanagawa, Japan
| | - Hiroka Nagaoka
- Faculty of Medicine, Department of Palliative and Supportive Care, University of Tsukuba, Tsukuba, Japan
| | - Naosuke Yokomichi
- Division of Palliative and Supportive Care, Seirei Mikatahara General Hospital, Hamamatsu, Japan
| | - Isseki Maeda
- Division of Palliative and Supportive Care, Seirei Mikatahara General Hospital, Hamamatsu, Japan
- Department of Palliative Care, Senri-chuo Hospital, Osaka, Japan
| | - Takashi Yamaguchi
- Department of Medicine, Division of Palliative Care, Konan Medical Center, Kobe, Japan
| | - Tatsuya Morita
- Division of Palliative and Supportive Care, Palliative Care Team, and Seirei Hospice, Seirei Mikatahara General Hospital, Hamamatsu, Shizuoka, Japan
| | | |
Collapse
|
2
|
Yoza N, Nakazawa R, Nishi T, Tsukada H, Shirai D, Adachi H, Yamada R, Matsumura K, Iwata T, Usuba W, Aida K, Hayakawa N, Sasaki H, Kikuchi E. [Early Experience with MRI-Ultrasound Fusion-Guided Prostate Biopsy in Our Institution]. Hinyokika Kiyo 2022; 68:291-294. [PMID: 36199207 DOI: 10.14989/actauroljap_68_9_291] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/16/2023]
Abstract
A total of 100 patients were retrospectively analyzed with magnetic resonance imaging-ultrasonography (MRI-US) fusion biopsy(KOELIS, TRINITY®) at our institution between October 2019 and May 2020. The median patient age was 71 years, median prostate specific antigen (PSA) level was 7.4 ng/ml, and median PSA-density was 0.183 mg/ml. Sixty-one of the patients were positive for cancer ; 14 of them were positive by targeted biopsy only, 9 were positive by systematic biopsy only, and 38 were positive by both. Clinically significant prostate cancer (CPSC ; Gleason Score ≥3+4 and % core ≥50%) was detected by target biopsies in 46 patients and by systematic biopsies in 33 patients. The positive core detection rate for CSPC was 32.5% for targeted biopsies and 7.0% for systematic biopsies(P<0.0001), with a significantly higher rate for targeted biopsies. These results indicate that in MRI-US fusion biopsy, targeted biopsy has a higher detection rate for cancer and a significantly higher detection rate for clinically significant prostate cancer compared with systematic biopsy.
Collapse
Affiliation(s)
- Naoto Yoza
- The Department of Urology, St Marianna University School of Medicine
| | - Ryuto Nakazawa
- The Department of Urology, St Marianna University School of Medicine
| | - Tomohiro Nishi
- The Department of Urology, St Marianna University School of Medicine
| | - Hikaru Tsukada
- The Department of Urology, St Marianna University School of Medicine
| | - Daisuke Shirai
- The Department of Urology, St Marianna University School of Medicine
| | - Hiroyuki Adachi
- The Department of Urology, St Marianna University School of Medicine
| | - Ryuji Yamada
- The Department of Urology, St Marianna University School of Medicine
| | - Kaori Matsumura
- The Department of Urology, St Marianna University School of Medicine
| | - Teppei Iwata
- The Department of Urology, St Marianna University School of Medicine
| | - Wataru Usuba
- The Department of Urology, St Marianna University School of Medicine
| | - Kouichirou Aida
- The Department of Urology, St Marianna University School of Medicine
| | - Nozomi Hayakawa
- The Department of Urology, St Marianna University School of Medicine
| | - Hideo Sasaki
- The Department of Urology, St Marianna University School of Medicine
| | - Eiji Kikuchi
- The Department of Urology, St Marianna University School of Medicine
| |
Collapse
|
3
|
Yamaguchi T, Mori M, Maeda I, Matsunuma R, Tanaka-Yagi Y, Nishi T, Kizawa Y, Tsuneto S, Shima Y, Masukawa K, Miyashita M. The impact of death rattle on bereaved families: not the sound itself, but the resonance with their feelings. Jpn J Clin Oncol 2022; 52:774-778. [PMID: 35446952 DOI: 10.1093/jjco/hyac055] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/26/2022] [Accepted: 03/30/2022] [Indexed: 11/13/2022] Open
Abstract
BACKGROUND This study aimed to explore (i) the consistency between physician-rated and bereaved family-perceived intensity of death rattle, (ii) the relationship between intensity of death rattle and the bereaved family's distress and (iii) the bereaved family's experience and feelings related to suctioning for death rattle. METHODS We used matched data for deceased patients from a prospective cohort study of cancer patients admitted to a palliative care unit, and their bereaved families from a nationwide questionnaire survey in Japan. The intensity of death rattle using Back's score was evaluated prospectively by physicians and retrospectively by bereaved families. RESULTS In total, 1122 bereaved families answered (response rate: 66.7%). Of these, 297 reported the development of death rattle. The maximum intensity of death rattle evaluated by physicians and perceived by bereaved families was poorly correlated (Spearman correlation coefficient 0.188, P = 0.082). The optimal cut-off point of Back's score for detecting high-level distress was 1/2, with a low accuracy of prediction (area under the curve 0.62). More than 70% of bereaved families indicated suctioning reduced the intensity of death rattle, made patients comfortable and themselves relieved, whereas a similar proportion felt patients were in distress during suctioning. Families who felt suctioning was gently performed and discussed well whether to do suctioning with health care providers felt less needs for improvement. CONCLUSIONS Bereaved family-perceived intensity of death rattle did not correlate to physician-evaluated intensity, and the intensity of death rattle itself seemed to poorly correlate to family distress. Gently performed suctioning based on sufficient discussion with families can help reduce family-perceived patient discomfort.
Collapse
Affiliation(s)
- Takashi Yamaguchi
- Department of Palliative Medicine, Kobe University Graduate School of Medicine, Kobe, Japan.,Department of Palliative Care, Konan Medical Center, Kobe, Japan
| | - Masanori Mori
- Department of Palliative and Supportive Care, Seirei Mikatahara General Hospital, Hamamatsu, Japan
| | - Isseki Maeda
- Department of Palliative Care, Senri Chuo Hospital, Suita, Japan
| | - Ryo Matsunuma
- Department of Palliative Medicine, Kobe University Graduate School of Medicine, Kobe, Japan.,Department of Palliative Care, Konan Medical Center, Kobe, Japan
| | - Yukako Tanaka-Yagi
- Department of Palliative Medicine, Kobe University Graduate School of Medicine, Kobe, Japan.,Department of Palliative Care, Konan Medical Center, Kobe, Japan
| | - Tomohiro Nishi
- Department of Palliative Care, Kawasaki Municipal Ida Hospital, Kawasaki, Japan
| | - Yoshiyuki Kizawa
- Department of Palliative Medicine, Kobe University Graduate School of Medicine, Kobe, Japan
| | - Satoru Tsuneto
- Department of Human Health Sciences, Graduate School of Medicine, Kyoto University, Kyoto, Japan
| | - Yasuo Shima
- Department of Palliative Medicine, Tsukuba Medical Center Hospital, Tsukuba, Japan
| | - Kento Masukawa
- Division of Palliative Nursing, Health Sciences, Tohoku University Graduate School of Medicine, Sendai, Japan
| | - Mitsunori Miyashita
- Division of Palliative Nursing, Health Sciences, Tohoku University Graduate School of Medicine, Sendai, Japan
| |
Collapse
|
4
|
Odagiri T, Maeda I, Masanori Mori, Morita T, Kaneishi K, Junko Nozato, Kazuhiro Kosugi, Higashibata T, Hamano J, Shimoinaba J, Nishi T, Kawashima N. Title: Effects of Antibiotics on Respiratory Symptoms in Terminally Ill Cancer Patients With Pneumonia: A Multicenter Cohort Study. Am J Hosp Palliat Care 2022; 39:1082-1089. [PMID: 35341338 DOI: 10.1177/10499091211058156] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
Abstract
CONTEXT Patients in the terminal stages of cancer are frequently affected by infection, especially pneumonia; but the effects of antibiotics on respiratory symptoms and factors associated with improvement are still unclear. OBJECTIVES This study aimed to clarify the effects of antibiotics on respiratory symptoms of terminally ill cancer patients with pneumonia, and to explore factors associated with the improvement. METHODS This was a prospective cohort study in which we consecutively recruited terminally ill cancer patients diagnosed with pneumonia and treated with antibiotics at one of 23 palliative care units across Japan. At the baseline and Day 3, primarily responsible palliative care specialists recorded patient backgrounds, the results of physical and laboratory examination, and patient symptoms using the Support Team Assessment Schedule. Improvement was defined as improvement of dyspnea, cough, and sputum production on Day 3. RESULTS Among all 1896 patients admitted during the study periods, 137 patients (7.2%) were enrolled into this study. Improvement was achieved in 65 patients (47.4%; 95% confidence intervals, 39-56). Univariate analyses revealed that the Palliative Prognostic Index (PPI), respiratory rate (RR), and oxygen requirement were significantly associated with the improvement. A multiple logistic regression analysis identified that PPI score of ≤ 6 and RR of <20 were independently associated with the improvement (odds ratios, 4.4 [1.6-12] and 2.5 [1.1-5.5], respectively). CONCLUSION Antibiotics may relieve respiratory symptoms from pneumonia in approximately half of the terminally ill cancer patients. PPI and respiratory rate are useful to identify the patients who received benefits of antibiotics.
Collapse
Affiliation(s)
- Takuya Odagiri
- Department of Palliative Care, Komaki City Hospital, Komaki, Japan
| | - Isseki Maeda
- Department of Palliative Care, Senri-chuo Hospital, Osaka, Japan
| | - Masanori Mori
- Palliative Care Team, Seirei Mikatahara General Hospital, Hamamatsu, Japan
| | - Tatsuya Morita
- Department of Palliative and Supportive Care, Seirei Mikatahara Genral Hospital, Hamamatsu, Japan
| | - Keisuke Kaneishi
- Department of Palliative Internal Medicine, JCHO Tokyo Shinjuku Medical Center, Tokyo, Japan
| | - Junko Nozato
- Department of Internal Medicine, Palliative Care, Medical Hospital, Tokyo Medical and Dental University, Tokyo, Japan
| | - Kazuhiro Kosugi
- Department of Palliative Medicine, 26351National Cancer Center Hospital East, Kashiwa, Japan
| | - Takahiro Higashibata
- Palliative Care Team, Department of General Medicine and Primary Care, 68320University of Tsukuba Hospital, Tsukuba, Japan
| | - Jun Hamano
- Division of Clinical Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan
| | | | - Tomohiro Nishi
- Kawasaki Municipal Ida Hospital, Kawasaki Comprehensive Care Center, Kawasaki, Japan
| | - Natsuki Kawashima
- Department of Palliative Medicine, 26420Tsukuba Medical Center Hospital, Tsukuba, Japan
| |
Collapse
|
5
|
Hashimoto T, Aikawa S, Akaishi T, Asano H, Bazzi M, Bennett DA, Berger M, Bosnar D, Butt AD, Curceanu C, Doriese WB, Durkin MS, Ezoe Y, Fowler JW, Fujioka H, Gard JD, Guaraldo C, Gustafsson FP, Han C, Hayakawa R, Hayano RS, Hayashi T, Hays-Wehle JP, Hilton GC, Hiraiwa T, Hiromoto M, Ichinohe Y, Iio M, Iizawa Y, Iliescu M, Ishimoto S, Ishisaki Y, Itahashi K, Iwasaki M, Ma Y, Murakami T, Nagatomi R, Nishi T, Noda H, Noumi H, Nunomura K, O'Neil GC, Ohashi T, Ohnishi H, Okada S, Outa H, Piscicchia K, Reintsema CD, Sada Y, Sakuma F, Sato M, Schmidt DR, Scordo A, Sekimoto M, Shi H, Shirotori K, Sirghi D, Sirghi F, Suzuki K, Swetz DS, Takamine A, Tanida K, Tatsuno H, Trippl C, Uhlig J, Ullom JN, Yamada S, Yamaga T, Yamazaki T, Zmeskal J. Measurements of Strong-Interaction Effects in Kaonic-Helium Isotopes at Sub-eV Precision with X-Ray Microcalorimeters. Phys Rev Lett 2022; 128:112503. [PMID: 35363014 DOI: 10.1103/physrevlett.128.112503] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/25/2021] [Accepted: 01/25/2022] [Indexed: 06/14/2023]
Abstract
We have measured the 3d→2p transition x rays of kaonic ^{3}He and ^{4}He atoms using superconducting transition-edge-sensor microcalorimeters with an energy resolution better than 6 eV (FWHM). We determined the energies to be 6224.5±0.4(stat)±0.2(syst) eV and 6463.7±0.3(stat)±0.1(syst) eV, and widths to be 2.5±1.0(stat)±0.4(syst) eV and 1.0±0.6(stat)±0.3(stat) eV, for kaonic ^{3}He and ^{4}He, respectively. These values are nearly 10 times more precise than in previous measurements. Our results exclude the large strong-interaction shifts and widths that are suggested by a coupled-channel approach and agree with calculations based on optical-potential models.
Collapse
Affiliation(s)
- T Hashimoto
- Advanced Science Research Center, Japan Atomic Energy Agency (JAEA), Tokai 319-1184, Japan
- RIKEN Cluster for Pioneering Research, RIKEN, Wako 351-0198, Japan
| | - S Aikawa
- Department of Physics, Tokyo Institute of Technology, Tokyo 152-8551, Japan
| | - T Akaishi
- Department of Physics, Osaka University, Toyonaka 560-0043, Japan
| | - H Asano
- RIKEN Cluster for Pioneering Research, RIKEN, Wako 351-0198, Japan
| | - M Bazzi
- Laboratori Nazionali di Frascati dell' INFN, Frascati I-00044, Italy
| | - D A Bennett
- National Institute of Standards and Technology, Boulder, Colorado 80305, USA
| | - M Berger
- Stefan-Meyer-Institut für subatomare Physik, Vienna A-1030, Austria
| | - D Bosnar
- Department of Physics, Faculty of Science, University of Zagreb, Zagreb 10000, Croatia
| | - A D Butt
- Politecnico di Milano, Dipartimento di Elettronica, Milano 20133, Italy
| | - C Curceanu
- Laboratori Nazionali di Frascati dell' INFN, Frascati I-00044, Italy
| | - W B Doriese
- National Institute of Standards and Technology, Boulder, Colorado 80305, USA
| | - M S Durkin
- National Institute of Standards and Technology, Boulder, Colorado 80305, USA
| | - Y Ezoe
- Department of Physics, Tokyo Metropolitan University, Tokyo 192-0397, Japan
| | - J W Fowler
- National Institute of Standards and Technology, Boulder, Colorado 80305, USA
| | - H Fujioka
- Department of Physics, Tokyo Institute of Technology, Tokyo 152-8551, Japan
| | - J D Gard
- National Institute of Standards and Technology, Boulder, Colorado 80305, USA
| | - C Guaraldo
- Laboratori Nazionali di Frascati dell' INFN, Frascati I-00044, Italy
| | - F P Gustafsson
- Stefan-Meyer-Institut für subatomare Physik, Vienna A-1030, Austria
| | - C Han
- RIKEN Cluster for Pioneering Research, RIKEN, Wako 351-0198, Japan
| | - R Hayakawa
- Department of Physics, Tokyo Metropolitan University, Tokyo 192-0397, Japan
| | - R S Hayano
- Department of Physics, The University of Tokyo, Tokyo 113-0033, Japan
| | - T Hayashi
- Institute of Space and Astronautical Science, Japan Aerospace Exploration Agency, Sagamihara 252-5210, Japan
| | - J P Hays-Wehle
- National Institute of Standards and Technology, Boulder, Colorado 80305, USA
| | - G C Hilton
- National Institute of Standards and Technology, Boulder, Colorado 80305, USA
| | - T Hiraiwa
- Research Center for Nuclear Physics (RCNP), Osaka University, Ibaraki 567-0047, Japan
| | - M Hiromoto
- Department of Physics, Osaka University, Toyonaka 560-0043, Japan
| | - Y Ichinohe
- Department of Physics, Rikkyo University, Tokyo 171-8501, Japan
| | - M Iio
- High Energy Accelerator Research Organization (KEK), Tsukuba 305-0801, Japan
| | - Y Iizawa
- Department of Physics, Tokyo Institute of Technology, Tokyo 152-8551, Japan
| | - M Iliescu
- Laboratori Nazionali di Frascati dell' INFN, Frascati I-00044, Italy
| | - S Ishimoto
- High Energy Accelerator Research Organization (KEK), Tsukuba 305-0801, Japan
| | - Y Ishisaki
- Department of Physics, Tokyo Metropolitan University, Tokyo 192-0397, Japan
| | - K Itahashi
- RIKEN Cluster for Pioneering Research, RIKEN, Wako 351-0198, Japan
| | - M Iwasaki
- RIKEN Cluster for Pioneering Research, RIKEN, Wako 351-0198, Japan
| | - Y Ma
- RIKEN Cluster for Pioneering Research, RIKEN, Wako 351-0198, Japan
| | - T Murakami
- Department of Physics, The University of Tokyo, Tokyo 113-0033, Japan
| | - R Nagatomi
- Department of Physics, Osaka University, Toyonaka 560-0043, Japan
| | - T Nishi
- RIKEN Nishina Center for Accelerator-Based Science, RIKEN, Wako 351-0198, Japan
| | - H Noda
- Department of Earth and Space Science, Osaka University, Toyonaka 560-0043, Japan
| | - H Noumi
- Research Center for Nuclear Physics (RCNP), Osaka University, Ibaraki 567-0047, Japan
| | - K Nunomura
- Department of Physics, Tokyo Metropolitan University, Tokyo 192-0397, Japan
| | - G C O'Neil
- National Institute of Standards and Technology, Boulder, Colorado 80305, USA
| | - T Ohashi
- Department of Physics, Tokyo Metropolitan University, Tokyo 192-0397, Japan
| | - H Ohnishi
- Research Center for Electron Photon Science (ELPH), Tohoku University, Sendai 982-0826, Japan
| | - S Okada
- RIKEN Cluster for Pioneering Research, RIKEN, Wako 351-0198, Japan
- Engineering Science Laboratory, Chubu University, Kasugai 487-8501, Japan
| | - H Outa
- RIKEN Cluster for Pioneering Research, RIKEN, Wako 351-0198, Japan
| | - K Piscicchia
- Laboratori Nazionali di Frascati dell' INFN, Frascati I-00044, Italy
| | - C D Reintsema
- National Institute of Standards and Technology, Boulder, Colorado 80305, USA
| | - Y Sada
- Research Center for Electron Photon Science (ELPH), Tohoku University, Sendai 982-0826, Japan
| | - F Sakuma
- RIKEN Cluster for Pioneering Research, RIKEN, Wako 351-0198, Japan
| | - M Sato
- High Energy Accelerator Research Organization (KEK), Tsukuba 305-0801, Japan
| | - D R Schmidt
- National Institute of Standards and Technology, Boulder, Colorado 80305, USA
| | - A Scordo
- Laboratori Nazionali di Frascati dell' INFN, Frascati I-00044, Italy
| | - M Sekimoto
- High Energy Accelerator Research Organization (KEK), Tsukuba 305-0801, Japan
| | - H Shi
- Stefan-Meyer-Institut für subatomare Physik, Vienna A-1030, Austria
| | - K Shirotori
- Research Center for Nuclear Physics (RCNP), Osaka University, Ibaraki 567-0047, Japan
| | - D Sirghi
- Laboratori Nazionali di Frascati dell' INFN, Frascati I-00044, Italy
| | - F Sirghi
- Laboratori Nazionali di Frascati dell' INFN, Frascati I-00044, Italy
| | - K Suzuki
- Stefan-Meyer-Institut für subatomare Physik, Vienna A-1030, Austria
| | - D S Swetz
- National Institute of Standards and Technology, Boulder, Colorado 80305, USA
| | - A Takamine
- RIKEN Cluster for Pioneering Research, RIKEN, Wako 351-0198, Japan
| | - K Tanida
- Advanced Science Research Center, Japan Atomic Energy Agency (JAEA), Tokai 319-1184, Japan
| | - H Tatsuno
- Department of Physics, Tokyo Metropolitan University, Tokyo 192-0397, Japan
| | - C Trippl
- Stefan-Meyer-Institut für subatomare Physik, Vienna A-1030, Austria
| | - J Uhlig
- Chemical Physics, Lund University, Lund 22100, Sweden
| | - J N Ullom
- National Institute of Standards and Technology, Boulder, Colorado 80305, USA
| | - S Yamada
- Department of Physics, Rikkyo University, Tokyo 171-8501, Japan
| | - T Yamaga
- RIKEN Cluster for Pioneering Research, RIKEN, Wako 351-0198, Japan
| | - T Yamazaki
- Department of Physics, The University of Tokyo, Tokyo 113-0033, Japan
| | - J Zmeskal
- Stefan-Meyer-Institut für subatomare Physik, Vienna A-1030, Austria
| |
Collapse
|
6
|
Yokota S, Amano K, Oyamada S, Ishiki H, Maeda I, Miura T, Hatano Y, Uneno Y, Hori T, Matsuda Y, Kohara H, Suzuki K, Morita T, Mori M, Inoue S, Yokomichi N, Imai K, Tsukuura H, Yamauchi T, Naito AS, Yoshioka A, Hiramoto S, Kikuchi A, Tanaka K, Kamei T, Azuma Y, Uno T, Miyamoto J, Katayama H, Kashiwagi H, Matsumoto E, Oya K, Yamaguchi T, Okamura T, Hashimoto H, Kosugi S, Ikuta N, Matsumoto Y, Ohmori T, Nakai T, Ikee T, Unoki Y, Kitade K, Koito S, Ishibashi N, Ehara M, Kuwahara K, Ueno S, Nakashima S, Ishiyama Y, Sakashita A, Matsunuma R, Takatsu H, Yamaguchi T, Ito S, Terabayashi T, Nakagawa J, Yamagiwa T, Inoue A, Yamaguchi T, Miyashita M, Yoshida S, Hiratsuka Y, Tagami K, Watanabe H, Odagiri T, Ito T, Ikenaga M, Shimizu K, Hayakawa A, Kamura R, Okoshi T, Nishi T, Kosugi K, Shibata Y, Hisanaga T, Higashibata T, Yabuki R, Hagiwara S, Shimokawa M, Miyake S, Nozato J, Appointed S, Iriyama T, Kaneishi K, Baba M, Matsumoto Y, Okizaki A, Watanabe YS, Uehara Y, Satomi E, Nishijima K, Shimoinaba J, Nakahori R, Hirohashi T, Hamano J, Kawashima N, Kawaguchi T, Uchida M, Sato K, Matsuda Y, Tsuneto S, Maeda S, Kizawa Y, Otani H. Effects of artificial nutrition and hydration on survival in patients with head and neck cancer and esophageal cancer admitted to palliative care units. Clinical Nutrition Open Science 2022. [DOI: 10.1016/j.nutos.2021.11.008] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022] Open
|
7
|
Kaneishi K, Morita T, Kohara H, Ito T, Nakagawa J, Nishi T, Inoue A, Oyamada S, Mori M. Epidemiology of Respiration with Mandibular Movement in Advanced Cancer Patients: A Multicenter Prospective Cohort Study. J Palliat Med 2021; 25:461-464. [PMID: 34964658 DOI: 10.1089/jpm.2021.0328] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022] Open
Abstract
Background: Respiration with mandibular movement (RMM) is one of the important clinical signs of impending death. However, there is very limited data on its natural course. Objective and Methods: This study was conducted in 23 inpatient palliative care units in Japan. It aimed to explore the natural course of RMM. Results: Among a total of 1526 cancer patients included, 1065 patients (69.8%) had RMM. A total of 14.8% patients experienced respiratory arrest within 30 minutes from RMM onset, 14.3% within 30-60 minutes, 34.4% within 1-4 hours, 17.5% within 4-12 hours, 8.9% within 12-24 hours, and 10.4%> 24 hours. Mean oxygen saturation and percentage of patients with SpO2 ≥90% at RMM onset were found to be significantly higher in patients with longer durations from RMM onset to death (p < 0.001). Conclusion: RMM occurred in a majority (80%) of dying patients within 12 hours. A minority of the patients survived >24 hours.
Collapse
Affiliation(s)
- Keisuke Kaneishi
- Department of Palliative Care Unit, JCHO Tokyo Shinjuku Medical Center, Tokyo, Japan
| | - Tatsuya Morita
- Palliative and Supportive Care Division, Seirei Mikatahara Hospital, Hamamatsu, Japan
| | - Hiroyuki Kohara
- Department of Palliative Care, Hiroshima Prefectural Hospital, Hiroshima, Japan
| | - Tetsuya Ito
- Department of Palliative Care, Japanese Red Cross Medical Center, Tokyo, Japan.,Department of Palliative Medicine and Advanced Clinical Oncology, IMSUT Hospital, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan
| | - Jun Nakagawa
- Hospice, The Japan Baptist Hospital, Kyoto, Japan
| | - Tomohiro Nishi
- Kawasaki Municipal Ida Hospital, Kawasaki Comprehensive Care Center, Kawasaki, Japan
| | - Akira Inoue
- Department of Palliative Medicine, Tohoku University School of Medicine, Sendai, Miyagi, Japan
| | | | - Masanori Mori
- Palliative and Supportive Care Division, Seirei Mikatahara Hospital, Hamamatsu, Japan
| |
Collapse
|
8
|
Amano K, Satomi E, Oyamada S, Ishiki H, Sakashita A, Miura T, Maeda I, Hatano Y, Yamauchi T, Oya K, Nakagawa J, Hiratsuka Y, Hirohashi T, Morita T, Mori M, Inoue S, Yokomichi N, Imai K, Tsukuura H, Naito AS, Uneno Y, Yoshioka A, Hiramoto S, Kikuchi A, Hori T, Matsuda Y, Kohara H, Funaki H, Tanaka K, Suzuki K, Kamei T, Azuma Y, Uno T, Miyamoto J, Katayama H, Kashiwagi H, Matsumoto E, Yamaguchi T, Okamura T, Hashimoto H, Kosugi S, Ikuta N, Matsumoto Y, Ohmori T, Nakai T, Ikee T, Unoki Y, Kitade K, Koito S, Ishibashi N, Ehara M, Kuwahara K, Ueno S, Nakashima S, Ishiyama Y, Matsunuma R, Takatsu H, Yamaguchi T, Ito S, Terabayashi T, Yamagiwa T, Inoue A, Yamaguchi T, Miyashita M, Yoshida S, Tagami K, Watanabe H, Odagiri T, Ito T, Ikenaga M, Shimizu K, Hayakawa A, Kamura R, Okoshi T, Nishi T, Kosugi K, Shibata Y, Hisanaga T, Higashibata T, Yabuki R, Hagiwara S, Shimokawa M, Miyake S, Nozato J, Iriyama T, Kaneishi K, Baba M, Matsumoto Y, Okizaki A, Sumazaki Watanabe Y, uehara Y, Nishijima K, Shimoinaba J, Nakahori R, Hamano J, Kawashima N, Kawaguchi T, Uchida M, Sato K, Matsuda Y, Tsuneto S, Maeda S, Kizawa Y, Otani H. The prevalence of artificially administered nutrition and hydration in different age groups among patients with advanced cancer admitted to palliative care units. Clinical Nutrition Open Science 2021. [DOI: 10.1016/j.nutos.2021.10.005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022] Open
|
9
|
Amano K, Maeda I, Ishiki H, Miura T, Hatano Y, Tsukuura H, Taniyama T, Matsumoto Y, Matsuda Y, Kohara H, Morita T, Mori M, Inoue S, Yokomichi N, Imai K, Yamauchi T, Naito AS, Uneno Y, Yoshioka A, Hiramoto S, Kikuchi A, Hori T, Funaki H, Tanaka K, Suzuki K, Kamei T, Azuma Y, Uno T, Miyamoto J, Katayama H, Kashiwagi H, Matsumoto E, Oya K, Yamaguchi T, Okamura T, Hashimoto H, Kosugi S, Ikuta N, Matsumoto Y, Ohmori T, Nakai T, Ikee T, Unoki Y, Kitade K, Koito S, Ishibashi N, Ehara M, Kuwahara K, Ueno S, Nakashima S, Ishiyama Y, Sakashita A, Matsunuma R, Takatsu H, Yamaguchi T, Ito S, Terabayashi T, Nakagawa J, Yamagiwa T, Inoue A, Yamaguchi T, Miyashita M, Yoshida S, Hiratsuka Y, Tagami K, Watanabe H, Odagiri T, Ito T, Ikenaga M, Shimizu K, Hayakawa A, Kamura R, Okoshi T, Nishi T, Kosugi K, Shibata Y, Hisanaga T, Higashibata T, Yabuki R, Hagiwara S, Shimokawa M, Miyake S, Nozato J, Iriyama T, Kaneishi K, Baba M, Okizaki A, Watanabe YS, Uehara Y, Satomi E, Nishijima K, Shimoinaba J, Nakahori R, Hirohashi T, Hamano J, Kawashima N, Kawaguchi T, Uchida M, Sato K, Matsuda Y, Tsuneto S, Maeda S, Kizawa Y, Otani H. Effects of enteral nutrition and parenteral nutrition on survival in patients with advanced cancer cachexia: Analysis of a multicenter prospective cohort study. Clin Nutr 2021; 40:1168-1175. [DOI: 10.1016/j.clnu.2020.07.027] [Citation(s) in RCA: 13] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/27/2020] [Revised: 07/07/2020] [Accepted: 07/20/2020] [Indexed: 12/18/2022]
|
10
|
Wong C, Nishi T, Ng M, Yong A, Ada C, Kakuta T, Barbato E, Waseda K, Amano T, Hirohata A, Fearon W. Elevated Microvascular Resistance in Conjunction With Reduced Coronary Flow Reserve Predicts Adverse Long-Term Outcomes After Percutaneous Coronary Intervention. Heart Lung Circ 2021. [DOI: 10.1016/j.hlc.2021.06.475] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
11
|
Nishi T, Matsunaga K, Mitsuoka T, Okimura Y, Katsu Y. Advanced superhard composite materials with extremely improved mechanical strength by interfacial segregation of dilute dopants. Sci Rep 2020; 10:21008. [PMID: 33273583 PMCID: PMC7712878 DOI: 10.1038/s41598-020-78064-0] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/13/2020] [Accepted: 11/19/2020] [Indexed: 11/18/2022] Open
Abstract
Control of heterointerfaces in advanced composite materials is of scientific and industrial importance, because their interfacial structures and properties often determine overall performance and reliability of the materials. Here distinct improvement of mechanical properties of alumina-matrix tungsten-carbide composites, which is expected for cutting-tool application for aerospace industries, is achieved via interfacial atomic segregation. It is found that only a small amount of Zr addition is unexpectedly effective to significantly increase their mechanical properties, and especially their bending strength reaches values far beyond those of conventional superhard composite materials. Atomic-resolution STEM observations show that doped Zr atoms are preferentially located only at interfaces between Al2O3 and WC grains, forming atomic segregation layers. DFT calculations indicate favorable thermodynamic stability of the interfacial Zr segregation due to structural transition at the interface. Moreover, theoretical works of separation demonstrate remarkable increase in interfacial strength through the interfacial structural transition, which strongly supports reinforcement of the interfaces by single-layer Zr segregation.
Collapse
Affiliation(s)
- Tomohiro Nishi
- Department of Materials Physics, Nagoya University, Furo-cho, Chikusa-ku, Nagoya, 464-8603, Japan.
- NGK Spark Plug Co., Ltd., Komaki-shi, Iwasaki, Aichi, 485-8510, Japan.
| | - Katsuyuki Matsunaga
- Department of Materials Physics, Nagoya University, Furo-cho, Chikusa-ku, Nagoya, 464-8603, Japan.
- Nanostructures Research Laboratory, Japan Fine Ceramics Center, 2-4-1, Atsuta-ku, Mutsuno, Nagoya, 456-8587, Japan.
| | - Takeshi Mitsuoka
- NGK Spark Plug Co., Ltd., Komaki-shi, Iwasaki, Aichi, 485-8510, Japan
| | - Yasuyuki Okimura
- NGK Spark Plug Co., Ltd., Komaki-shi, Iwasaki, Aichi, 485-8510, Japan
| | - Yusuke Katsu
- NGK Spark Plug Co., Ltd., Komaki-shi, Iwasaki, Aichi, 485-8510, Japan
| |
Collapse
|
12
|
Tatekawa S, Shimamoto S, Nishi T, Tani M, Ohsima T, Onosaka S, Komeya Y, Yamashita Y, Tamari K, Ogawa K. PO-0853: The effect of the smoking cessation for radiation therapy of glottis carcinoma with monitoring CO. Radiother Oncol 2020. [DOI: 10.1016/s0167-8140(21)00870-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
13
|
Hiratsuka Y, Suh SY, Maeda I, Morita T, Mori M, Ito S, Nishi T, Hisanaga T, Iriyama T, Kaneishi K, Ikari T, Tagami K, Inoue A. Factors influencing spiritual well-being in terminally ill cancer inpatients in Japan. Support Care Cancer 2020; 29:2795-2802. [DOI: 10.1007/s00520-020-05802-5] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/26/2020] [Accepted: 09/24/2020] [Indexed: 11/25/2022]
|
14
|
Hozumi T, Morimoto J, Nishi T, Takemoto K, Fujita S, Wada T, Shimamura K, Kashiawagi M, Shiono Y, Kuroi A, Matsuo Y, Ino Y, Kubo T, Tanaka A, Akasaka T. P1518 Relationship between post-operative asymptomatic status and reverse remodeling of large left atrium in patients with aortic stenosis who underwent aortic valve replacement. Eur Heart J Cardiovasc Imaging 2020. [DOI: 10.1093/ehjci/jez319.942] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Introduction
Recently, we have reported that large left atrial volume (minimum left atrial volume index : LAVImin ≥30ml/m²) at end-diastole determined by direct exposure of left ventricular (LV) end-diastolic pressure can predict post-operative symptomatic status after aortic valve replacement (AVR) in aortic stenosis (AS) patients with high sensitivity and modest specificity. Reverse remodeling of large LAVImin after AVR may contribute to false positive for the prediction of post-operative symptomatic status in patients with AS.
Purpose
The purpose of this study was to evaluate relationship between post-operative symptomatic status and reverse remodeling of large LAVImin in patients with AS who underwent AVR.
Methods
The study population consisted of 75 patients with AS who underwent AVR and were followed up for 600 days after AVR, after the exclusion of the followings; atrial fibrillation, significant coronary artery disease, significant mitral valve disease, pacemaker rhythm, and inadequate echocardiographic images. We measured LAVImin by biplane Simpson"s method before and after AVR. Preoperative large LAVImin (≥30ml/m²) according to the previous study was observed in 32 (43%) of 75 patients. We divided these 32 patients into two groups according to the post-operative symptomatic status during the follow-up period.
Results
There was no significant difference in pre-operative LAVImin between patients with and without post-operative symptom (46.5 ± 13.4 vs 40.4 ± 8.6 ml/m²). On the other hand, post-operative LAVImin in patients without post-operative symptom was significantly smaller than that in patients with post-operative symptom (31.5 ± 8.6 vs 54.8 ± 14.0 ml/m², p < 0.01). While significant regression in LAVImin after AVR was observed in patients without post-operative symptom (40.4 ± 8.6 to 31.5 ± 8.6 ml/m², p < 0.05), no regression in LAVImin after AVR was observed in patients with post-operative symptom (46.5 ± 13.4 to 54.8 ± 14.0 ml/m²).
Conclusions
Reverse remodeling of large LAVmin in patients with AS who underwent AVR was observed in post-operative asymptomatic group, but not in symptomatic group. These results suggest that reverse remodeling of large LAVImin after AVR could contribute to the post-operative asymptomatic status in patients with AS who underwent AVR.
Collapse
Affiliation(s)
- T Hozumi
- Wakayama Medical University, Wakayama, Japan
| | - J Morimoto
- Wakayama Medical University, Wakayama, Japan
| | - T Nishi
- Wakayama Medical University, Wakayama, Japan
| | - K Takemoto
- Wakayama Medical University, Wakayama, Japan
| | - S Fujita
- Wakayama Medical University, Wakayama, Japan
| | - T Wada
- Wakayama Medical University, Wakayama, Japan
| | - K Shimamura
- Wakayama Medical University, Wakayama, Japan
| | | | - Y Shiono
- Wakayama Medical University, Wakayama, Japan
| | - A Kuroi
- Wakayama Medical University, Wakayama, Japan
| | - Y Matsuo
- Wakayama Medical University, Wakayama, Japan
| | - Y Ino
- Wakayama Medical University, Wakayama, Japan
| | - T Kubo
- Wakayama Medical University, Wakayama, Japan
| | - A Tanaka
- Wakayama Medical University, Wakayama, Japan
| | - T Akasaka
- Wakayama Medical University, Wakayama, Japan
| |
Collapse
|
15
|
Mori M, Morita T, Matsuda Y, Yamada H, Kaneishi K, Matsumoto Y, Matsuo N, Odagiri T, Aruga E, Watanabe H, Tatara R, Sakurai H, Kimura A, Katayama H, Suga A, Nishi T, Shirado AN, Watanabe T, Kuchiba A, Yamaguchi T, Iwase S. How successful are we in relieving terminal dyspnea in cancer patients? A real-world multicenter prospective observational study. Support Care Cancer 2019; 28:3051-3060. [DOI: 10.1007/s00520-019-05081-9] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/23/2019] [Accepted: 09/16/2019] [Indexed: 12/19/2022]
|
16
|
Izawa N, Shiokawa H, Onuki R, Hamaji K, Furuya N, Ohashi H, Nishi T, Kasugai S, Arai H, Doi A, Horie Y, Hirakawa M, Mizukami T, Ogura T, Tsuda T, Sunakawa Y, Nakajima T. Association of gastric acid suppression with efficacy of immune checkpoint inhibitors (ICIs) in advanced cancer patients. Ann Oncol 2019. [DOI: 10.1093/annonc/mdz338.108] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
17
|
Hozumi T, Nozawa Y, Takemoto K, Nishi T, Wada T, Maniwa N, Kashiwagi K, Shimamura K, Kuroi A, Matsuo Y, Kitabata H, Ino Y, Kubo T, Tanaka A, Akasaka T. P3365Relationship between early diastolic intra-ventricular pressure gradient shortly after aortic valve closure estimated by vector flow mapping and left ventricular diastolic untwisting rate in humans. Eur Heart J 2019. [DOI: 10.1093/eurheartj/ehz745.0241] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Abstract
Background
Early diastolic suction is an important determinant of early diastolic function. Previous studies using color Doppler M-mode and speckle-tracking echocardiography have shown left ventricular (LV) early diastolic LV untwisting rate is directly related to LV intra-ventricular pressure gradient (IVPG) between LV base and apex during early diastole. Recent introduction of vector flow mapping (VFM) using combination of color Doppler and speckle-tracking echocardiography provides noninvasive and feasible assessment of early diastolic IVPG shortly after aortic valve closure including isovolmic relaxation period (ED-IVPG) in humans. However, relationship between VFM–derived ED-IVPG and early diastolic LV untwisting rate has not been well investigated.
Purpose
The purpose of this study was to examine relationship between ED-IVPG estimated by VFM and LV untwisting rate by speckle-tracking echocardiography.
Methods
The study population consists of 66 patients without segmental wall motion abnormality, significant valvular diseases, and atrial fibrillation who underwent echocardiography for evaluation of LV function (age: 60±15 years, LVEF: 49±16%). From the apical long-axis views by color Doppler echocardiography, we analyzed peak ED-IVPG between LV base and apex just after aortic valve closure (figure) using commercially available VFM analysis software (DAS-RS1, Hitachi). We assessed peak early diastolic LV untwisting rate and LV torsion from LV basal and apical short-axis view by speckle-tracking echocardiography. We evaluated correlation between ED-IVPG and LV untwisting rate. We also evaluated correlation between ED-IVPG and peak systolic LV torsion, LV end-diastolic (EDV) and end-systolic volumes (ESV), ejection fraction (EF), early diastolic velocity (E) of LV inflow, average early diastolic velocity (e') of mitral annulus, and average E/e'.
Results
In all the study patients, ED-IVPG was successfully and quickly evaluated. 1) ED-IVPG correlated well with peak LV untwisting rate (r=0.64, p<0.0001). 2) ED-IVPG significantly correlated with LV torsion, LVEDV, LVESV, and LVEF (r=0.47, r=−0.48, r=−0.46, and r=0.48, respectively, p<0.001). 3) There were no significant correlations between ED-IVPG and other indexes including E, average e', and average E/e'. According to receiver operating characteristic analysis, the best cut-off value of ED-IVPG for determining impaired LV untwisting rate (<80 degrees/s) was found at 0.42 mmHg (sensitivity 81%, specificity 76%, and area under the curve 0.86)
ED-IVPG measurement by VFM
Conclusions
The present results showed that noninvasive VFM-derived peak ED-IVPG shortly after aortic valve closure is related to early diastolic peak LV untwisting rate. ED-IVPG easily and quickly estimated by VFM may be used as an additional index for LV diastolic function.
Collapse
Affiliation(s)
- T Hozumi
- Wakayama Medical University, Wakayama, Japan
| | - Y Nozawa
- Wakayama Medical University, Wakayama, Japan
| | - K Takemoto
- Wakayama Medical University, Wakayama, Japan
| | - T Nishi
- Wakayama Medical University, Wakayama, Japan
| | - T Wada
- Wakayama Medical University, Wakayama, Japan
| | - N Maniwa
- Wakayama Medical University, Wakayama, Japan
| | - K Kashiwagi
- Wakayama Medical University, Wakayama, Japan
| | - K Shimamura
- Wakayama Medical University, Wakayama, Japan
| | - A Kuroi
- Wakayama Medical University, Wakayama, Japan
| | - Y Matsuo
- Wakayama Medical University, Wakayama, Japan
| | - H Kitabata
- Wakayama Medical University, Wakayama, Japan
| | - Y Ino
- Wakayama Medical University, Wakayama, Japan
| | - T Kubo
- Wakayama Medical University, Wakayama, Japan
| | - A Tanaka
- Wakayama Medical University, Wakayama, Japan
| | - T Akasaka
- Wakayama Medical University, Wakayama, Japan
| |
Collapse
|
18
|
Nishi T, Hozumi T, Takemoto K, Wada T, Maniwa N, Kashiwagi M, Shimamura K, Shiono Y, Kuroi A, Matsuo Y, Kitabata H, Ino Y, Kubo T, Tanaka A, Akasaka T. P4349Simple and rapid estimation of left ventricular longitudinal deformation by tissue-tracking mitral annular displacement in single apical view. Eur Heart J 2019. [DOI: 10.1093/eurheartj/ehz745.0757] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background
Noninvasive assessment of left ventricular (LV) deformation using global longitudinal strain (GLS) has prognostic value in patients with and without preserved ejection fraction (EF). Application of speckle-tracking technology to the mitral annulus provides rapid and easy assessment of displacement of septal and lateral mitral annulus and mid-point of mitral annular line in single apical view (TMAD) even in poor echo-image quality. TMAD may be used as a simple index of LV longitudinal deformation in patients with and without preserved EF (Figure).
Purpose
The purpose of this study was to examine whether TMAD can be used as a simple index of LV longitudinal deformation in patients with and without preserved EF.
Methods
The study population consists of 95 patients without segmental wall motion abnormality, significant valvular diseases, and atrial fibrillation in whom both TMAD and GLS measurements were applied by QLAB software (Philips). We estimated GLS from apical 4- and 2-chamber views and apical longitudinal views, and TMAD from apical 4-chamber view. TMAD was automatically and quickly evaluated as the base-to-apex displacement of septal (TMADsep), lateral (TMADlat), and mid-point of annular line (TMADmid) (Figure). The percentage of M-TMAD to LV length from the mid-point of mitral annuls to the apex at end-diastole (%TMADmid) was also calculated. We compared each TMAD values with GLS values by linear regression analysis, and evluated TMAD values by a receiver operating characteristic (ROC) analysis to detect impaired LV longitudinal deformation (|GLS|<12.0%).
Results
TMAD was successfully assessed in 94 of 95 patients (99%) while GLS was measured in 84 of 95 patients (87%, p=0.0082 vs TMAD). There were good correlations between each TMAD index and |GLS| (TMADsep:r=0.77, TMADlat:r=0.81, TMADmid:r=0.82, %TMADmid:r=0.87). According to ROC curve, the best cut-off values for TMADsep, TMADlat, TMADmid, and %TMADmid in determining LV longitudinal deformation were 6.8mm, 8.0mm, 7.8mm, and 9.5% respectively (Table).
Conclusions
The present results suggest that rapid and easy assessment of TMAD in single apical view may be used as a simple index of LV longitudinal deformation.
Collapse
Affiliation(s)
- T Nishi
- Wakayama Medical University, Wakayama, Japan
| | - T Hozumi
- Wakayama Medical University, Wakayama, Japan
| | - K Takemoto
- Wakayama Medical University, Wakayama, Japan
| | - T Wada
- Wakayama Medical University, Wakayama, Japan
| | - N Maniwa
- Wakayama Medical University, Wakayama, Japan
| | - M Kashiwagi
- Wakayama Medical University, Wakayama, Japan
| | - K Shimamura
- Wakayama Medical University, Wakayama, Japan
| | - Y Shiono
- Wakayama Medical University, Wakayama, Japan
| | - A Kuroi
- Wakayama Medical University, Wakayama, Japan
| | - Y Matsuo
- Wakayama Medical University, Wakayama, Japan
| | - H Kitabata
- Wakayama Medical University, Wakayama, Japan
| | - Y Ino
- Wakayama Medical University, Wakayama, Japan
| | - T Kubo
- Wakayama Medical University, Wakayama, Japan
| | - A Tanaka
- Wakayama Medical University, Wakayama, Japan
| | - T Akasaka
- Wakayama Medical University, Wakayama, Japan
| |
Collapse
|
19
|
Mori M, Fujimori M, Ishiki H, Nishi T, Hamano J, Otani H, Uneno Y, Oba A, Morita T, Uchitomi Y. The Effects of Adding Reassurance Statements: Cancer Patients' Preferences for Phrases in End-of-Life Discussions. J Pain Symptom Manage 2019; 57:1121-1129. [PMID: 30818028 DOI: 10.1016/j.jpainsymman.2019.02.019] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/29/2019] [Revised: 02/18/2019] [Accepted: 02/20/2019] [Indexed: 11/23/2022]
Abstract
CONTEXT When discussing end-of-life issues with cancer patients, the addition of reassurance statements is considered helpful. However, patients' preferences for such statements have not been systematically demonstrated. OBJECTIVES The objectives of this study were to clarify if phrases with additional reassurance statements would be more preferable to phrases without them and explore variables associated with patients' preferences. METHODS In a cross-sectional survey, 412 cancer patients assessed their own preferences for phrases with/without additional statements using a six-point scale (1 = not at all preferable; 6 = very preferable). These included the statements of "hope for the best and prepare for the worst" ("hope/prepare") when discussing prognosis; symptom palliation when discussing code status; and specific goals, continuity of care, and nonabandonment when discussing hospice referral. We evaluated demographic data and the coping style and conducted multivariate regression analysis. RESULTS Compared with the phrase of life expectancy (i.e., median + typical range) alone [mean (SD), 3.5 (1.2); 95% CI, 3.4-3.6], the phrase with the additional "hope/prepare" statement was more preferable [3.8 (1.4); 3.7-3.9]. Compared with the phrase of do-not-resuscitate alone (3.1(1.3); 3.0-3.3), the phrase with the additional statement of symptom palliation was more preferable [3.9 (1.3); 3.7-4.0]. Compared with the phrase of hospice referral alone [3.4 (1.2); 3.3-3.5], phrases with the addition of a specific goal [3.9 (1.0); 3.8-4.0], specific goal and continuity (4.4(1.0); 4.3-4.5), and specific goal, continuity, and nonabandonment [4.8 (1.2); 4.7-4.9] were more preferable. In multivariate analyses, task-oriented coping was significantly correlated with preferences for phrases including additional reassurance statements. CONCLUSION Cancer patients systematically preferred reassurance statements. In end-of-life discussions, especially with patients with task-oriented coping, clinicians may provide additional reassurance statements.
Collapse
Affiliation(s)
- Masanori Mori
- Palliative Care Team, Seirei Mikatahara General Hospital, Hamamatsu, Japan; Division of Health Care Research, QOL Research Group, Center for Public Health Sciences, National Cancer Center, Tokyo, Japan.
| | - Maiko Fujimori
- Division of Health Care Research, QOL Research Group, Center for Public Health Sciences, National Cancer Center, Tokyo, Japan; Division of Cohort Consortium Research, Epidemiology and Prevention Group, Center for Public Health Sciences, National Cancer Center, Tokyo, Japan
| | - Hiroto Ishiki
- Department of Palliative Medicine, National Cancer Center, Tokyo, Japan
| | - Tomohiro Nishi
- Kawasaki Comprehensive Care Center, Kawasaki Municipal Ida Hospital, Kawasaki, Japan
| | - Jun Hamano
- Division of Clinical Medicine, Faculty of Medicine, University of Tsukuba, Ibaraki, Japan
| | - Hiroyuki Otani
- Department of Palliative Care Team, and Palliative and Supportive Care, National Kyushu Cancer Center, Fukuoka, Japan
| | - Yu Uneno
- Department of Therapeutic Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan; Seirei Hospice, Seirei Mikatahara General Hospital, Hamamatsu, Japan
| | - Akira Oba
- Patient Support Center, Gunma Prefectural Cancer Center, Ota, Gunma, Japan
| | - Tatsuya Morita
- Palliative and Supportive Care Division, Seirei Mikatahara General Hospital, Hamamatsu, Japan
| | - Yosuke Uchitomi
- Division of Cohort Consortium Research, Epidemiology and Prevention Group, Center for Public Health Sciences, National Cancer Center, Tokyo, Japan; Innovation Center for Supportive, Palliative and Psychosocial Care, National Cancer Center Hospital, Tokyo, Japan
| |
Collapse
|
20
|
Mori M, Fujimori M, Ishiki H, Nishi T, Hamano J, Otani H, Uneno Y, Oba A, Morita T, Uchitomi Y. Adding a Wider Range and "Hope for the Best, and Prepare for the Worst" Statement: Preferences of Patients with Cancer for Prognostic Communication. Oncologist 2019; 24:e943-e952. [PMID: 30782978 DOI: 10.1634/theoncologist.2018-0643] [Citation(s) in RCA: 18] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/28/2018] [Accepted: 01/09/2019] [Indexed: 11/17/2022] Open
Abstract
INTRODUCTION Although various phrases to communicate prognoses based on a certain concept have been proposed, no study has systematically investigated preferences of patients with cancer for actual phrases. We investigated whether phrases with a wider range and additional "hope for the best, and prepare for the worst" (hope/prepare) statement would be more preferable and explored variables associated with patients' preferences. MATERIALS AND METHODS In a cross-sectional survey, 412 outpatients with cancer self-assessed their preferences for 13 phrases conveying prognostic information (e.g., phrases with or without median, typical range, and/or best/worst cases, and those with or without a hope/prepare statement) on a 6-point scale (1 = not at all preferable; 6 = very preferable). We evaluated demographic data and the Coping Inventory for Stressful Situations and conducted multivariate regression analysis. RESULTS Regarding phrases with various ranges, the one including the median, typical range, and best/worst cases was more preferable (mean ± SD, 3.8 ± 1.3; 95% confidence interval [CI], 3.6-3.9) than the one with the median and typical range (3.4 ± 1.2; 3.3-3.6) or the one with only the median (3.2 ± 1.3; 3.1-3.3). Concerning the hope/prepare statement, the phrase including the median, typical range, uncertainty, and hope/prepare statement was more preferable (3.8 ± 1.4; 3.7-3.9) than the one without the statement (3.5 ± 1.2; 3.4-3.6). In multivariate analyses, task-oriented coping was significantly correlated with preferences for phrases with explicit information. CONCLUSION Overall, phrases with a wider range and the hope/prepare statement were preferable to those without them. When patients with cancer ask about prognoses, especially those with task-oriented coping, clinicians may provide explicit information with a wider range and the hope/prepare statement. IMPLICATIONS FOR PRACTICE Discussing prognoses with patients with advanced cancer is among the most important conversations for clinicians. In this cross-sectional survey to systematically investigate preferences of 412 patients with cancer for phrases conveying prognostic information, phrases with the median, typical range, and best/worst cases and those with the "hope for the best and prepare for the worst" (hope/prepare) statement were the most preferred. When patients with cancer ask about prognoses, clinicians may provide explicit information with a wider range and include the hope/prepare statement.
Collapse
Affiliation(s)
- Masanori Mori
- Palliative Care Team, Seirei Mikatahara General Hospital, Hamamatsu, Japan
- Division of Health Care Research, QOL Research Group, Center for Public Health Sciences, National Cancer Center, Tokyo, Japan
| | - Maiko Fujimori
- Division of Health Care Research, QOL Research Group, Center for Public Health Sciences, National Cancer Center, Tokyo, Japan
- Division of Cohort Consortium Research, Epidemiology and Prevention Group, Center for Public Health Sciences, National Cancer Center, Tokyo, Japan
| | - Hiroto Ishiki
- Department of Palliative Medicine, National Cancer Center, Tokyo, Japan
| | - Tomohiro Nishi
- Kawasaki Comprehensive Care Center, Kawasaki Municipal Ida Hospital, Kawasaki, Japan
| | - Jun Hamano
- Division of Clinical Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan
| | - Hiroyuki Otani
- Department of Palliative Care Team, and Palliative and Supportive Care, National Kyushu Cancer Center, Fukuoka, Japan
| | - Yu Uneno
- Seirei Hospice, Seirei Mikatahara General Hospital, Hamamatsu, Japan
- Department of Therapeutic Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan
| | - Akira Oba
- Patient Support Center, Gunma Prefectural Cancer Center, Ota, Gunma, Japan
| | - Tatsuya Morita
- Palliative and Supportive Care Division, Seirei Mikatahara General Hospital, Hamamatsu, Japan
| | - Yosuke Uchitomi
- Division of Cohort Consortium Research, Epidemiology and Prevention Group, Center for Public Health Sciences, National Cancer Center, Tokyo, Japan
- Innovation Center for Supportive, Palliative and Psychosocial Care, National Cancer Center, Tokyo, Japan
| |
Collapse
|
21
|
Nishi T. [Home Visit and Palliative Care from Hospital]. Gan To Kagaku Ryoho 2019; 46:224-227. [PMID: 30914522] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/09/2023]
Abstract
At Kawasaki Municipal Ida Hospital, medical oncology and palliative care have been integrated, and we have been building the "embedded palliative care model" which is responsible for anticancer drugs to home care. In the visit clinical practice in this model, it was possible to prepare the medicine immediately even in the emergency against the background that there are abundant medicines in the hospital pharmacies, so it is aggressive to prepare the home comfort set there was not. However, problems due to lack of comfort set at home came to be found, and I began to think that discussion should start on that creation. In this article, we outline how to think of comfort set in visit medical treatment from hospital, large scale clinic etc.
Collapse
Affiliation(s)
- Tomohiro Nishi
- Kawasaki Comprehensive Care Center, Kawasaki Municipal Ida Hospital
| |
Collapse
|
22
|
Li JC, Zhang HS, Zhao XY, Jiang JG, Wu YX, Lu YL, Zhang LQ, Nishi T. Development of high damping natural rubber/butyl rubber composites compatibilized by isobutylene-isoprene block copolymer for isolation bearing. EXPRESS POLYM LETT 2019. [DOI: 10.3144/expresspolymlett.2019.58] [Citation(s) in RCA: 13] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022] Open
|
23
|
Derimay F, Rioufol G, Fearon W, Kobayashi Y, Nishi T, Finet G. Optimal balloon positioning to maximize the proximal optimization technique (POT). Archives of Cardiovascular Diseases Supplements 2019. [DOI: 10.1016/j.acvdsp.2018.10.043] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
24
|
Sasaki H, Nakamura H, Ono H, Yoshino S, Sakurai Y, Yoza N, Iwata T, Matsumura K, Satoh Y, Aoki N, Usuba W, Nishi T, Katsuoka Y, Nakazawa R. Routine Referral by Urologists Increase Opportunities for Corneal Donation. Transplant Proc 2018; 50:2986-2991. [PMID: 30577158 DOI: 10.1016/j.transproceed.2018.09.005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/25/2018] [Accepted: 09/05/2018] [Indexed: 11/29/2022]
Abstract
BACKGROUND The levels of corneal donation are insufficient to meet the demand for corneal transplantation in Japan. To overcome this problem, we started to routinely mention the possibility of corneal donation to the families of patients who died in our hospital's Urology Department in February 2008. In this study, we evaluated the effectiveness of this approach. METHODS We retrospectively reviewed the medical records of the patients who died in the Department of Urology, St. Marianna University School of Medicine Hospital, and analyzed the patients' characteristics and information about corneal donation. RESULTS In total, 211 patients died in our department between February 2008 and March 2017, and 155 patients were medically suitable corneal donors. We mentioned the possibility of corneal donation to 129 (83.2%) families, and 29 (18.7%) families agreed. Three families subsequently withdrew their consent. Finally, 26 (16.8%) of the families that were approached about corneal donation by urologists agreed to donate their relatives' corneas. Another 2 families voluntarily offered to donate their relatives' corneas. Thus, 28 (18.1%) of 155 medically suitable donors donated their corneas for transplantation. Twenty-six (92.8%) donors were 60 years or older and all donors were affected with malignant genitourinary tumors. Fifty-four (96.4%) corneas were successfully transplanted into recipients. CONCLUSIONS Even elderly patients who die of solid carcinoma can be an important source of corneal donors. In this study, we showed that routine referral by urologists increased corneal donation. If this approach were adopted by other departments, it might further increase the number of corneal donations.
Collapse
Affiliation(s)
- H Sasaki
- Department of Urology, St. Marianna University School of Medicine, Kawasaki, Kanagawa, Japan.
| | - H Nakamura
- Transplant Support Service, St. Marianna University Hospital, Kawasaki, Kanagawa, Japan
| | - H Ono
- Transplant Support Service, St. Marianna University Hospital, Kawasaki, Kanagawa, Japan
| | - S Yoshino
- Transplant Support Service, St. Marianna University Hospital, Kawasaki, Kanagawa, Japan
| | - Y Sakurai
- Transplant Support Service, St. Marianna University Hospital, Kawasaki, Kanagawa, Japan
| | - N Yoza
- Department of Urology, St. Marianna University School of Medicine, Kawasaki, Kanagawa, Japan
| | - T Iwata
- Department of Urology, St. Marianna University School of Medicine, Kawasaki, Kanagawa, Japan
| | - K Matsumura
- Department of Urology, St. Marianna University School of Medicine, Kawasaki, Kanagawa, Japan
| | - Y Satoh
- Department of Urology, St. Marianna University School of Medicine, Kawasaki, Kanagawa, Japan
| | - N Aoki
- Department of Urology, St. Marianna University School of Medicine, Kawasaki, Kanagawa, Japan
| | - W Usuba
- Department of Urology, St. Marianna University School of Medicine, Kawasaki, Kanagawa, Japan
| | - T Nishi
- Department of Urology, St. Marianna University School of Medicine, Kawasaki, Kanagawa, Japan
| | - Y Katsuoka
- Department of Urology, St. Marianna University School of Medicine, Kawasaki, Kanagawa, Japan
| | - R Nakazawa
- Department of Urology, St. Marianna University School of Medicine, Kawasaki, Kanagawa, Japan
| |
Collapse
|
25
|
Nishi T, Itahashi K, Berg GPA, Fujioka H, Fukuda N, Fukunishi N, Geissel H, Hayano RS, Hirenzaki S, Ichikawa K, Ikeno N, Inabe N, Itoh S, Iwasaki M, Kameda D, Kawase S, Kubo T, Kusaka K, Matsubara H, Michimasa S, Miki K, Mishima G, Miya H, Nagahiro H, Nakamura M, Noji S, Okochi K, Ota S, Sakamoto N, Suzuki K, Takeda H, Tanaka YK, Todoroki K, Tsukada K, Uesaka T, Watanabe YN, Weick H, Yamakami H, Yoshida K. Spectroscopy of Pionic Atoms in ^{122}Sn(d,^{3}He) Reaction and Angular Dependence of the Formation Cross Sections. Phys Rev Lett 2018; 120:152505. [PMID: 29756883 DOI: 10.1103/physrevlett.120.152505] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/24/2017] [Revised: 02/07/2018] [Indexed: 06/08/2023]
Abstract
We observed the atomic 1s and 2p states of π^{-} bound to ^{121}Sn nuclei as distinct peak structures in the missing mass spectra of the ^{122}Sn(d,^{3}He) nuclear reaction. A very intense deuteron beam and a spectrometer with a large angular acceptance let us achieve a potential of discovery, which includes the capability of determining the angle-dependent cross sections with high statistics. The 2p state in a Sn nucleus was observed for the first time. The binding energies and widths of the pionic states are determined and found to be consistent with previous experimental results of other Sn isotopes. The spectrum is measured at finite reaction angles for the first time. The formation cross sections at the reaction angles between 0° and 2° are determined. The observed reaction-angle dependence of each state is reproduced by theoretical calculations. However, the quantitative comparison with our high-precision data reveals a significant discrepancy between the measured and calculated formation cross sections of the pionic 1s state.
Collapse
Affiliation(s)
- T Nishi
- Department of Physics, School of Science, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, 113-0033 Tokyo, Japan
- Nishina Center for Accelerator-Based Science, RIKEN, 2-1 Hirosawa, Wako, 351-0198 Saitama, Japan
| | - K Itahashi
- Nishina Center for Accelerator-Based Science, RIKEN, 2-1 Hirosawa, Wako, 351-0198 Saitama, Japan
| | - G P A Berg
- Department of Physics and the Joint Institute for Nuclear Astrophysics Center for the Evolution of the Elements, University of Notre Dame, Notre Dame, Indiana 46556, USA
| | - H Fujioka
- Department of Physics, Kyoto University, Kitashirakawa-Oiwakecho, Sakyo-ku, Kyoto, 606-8502 Kyoto, Japan
| | - N Fukuda
- Nishina Center for Accelerator-Based Science, RIKEN, 2-1 Hirosawa, Wako, 351-0198 Saitama, Japan
| | - N Fukunishi
- Nishina Center for Accelerator-Based Science, RIKEN, 2-1 Hirosawa, Wako, 351-0198 Saitama, Japan
| | - H Geissel
- GSI Helmholtzzentrum für Schwerionenforschung GmbH, Planckstrasse 1, D-64291 Darmstadt, Germany
| | - R S Hayano
- Department of Physics, School of Science, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, 113-0033 Tokyo, Japan
| | - S Hirenzaki
- Department of Physics, Nara Women's University, Kita-Uoya Nishimachi, Nara, 630-8506 Nara, Japan
| | - K Ichikawa
- Department of Physics, School of Science, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, 113-0033 Tokyo, Japan
| | - N Ikeno
- Department of Life and Environmental Agricultural Sciences, Faculty of Agriculture, Tottori University, 4-101 Koyamacho-Minami, Tottori, 680-8551 Tottori, Japan
| | - N Inabe
- Nishina Center for Accelerator-Based Science, RIKEN, 2-1 Hirosawa, Wako, 351-0198 Saitama, Japan
| | - S Itoh
- Department of Physics, School of Science, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, 113-0033 Tokyo, Japan
| | - M Iwasaki
- Nishina Center for Accelerator-Based Science, RIKEN, 2-1 Hirosawa, Wako, 351-0198 Saitama, Japan
| | - D Kameda
- Nishina Center for Accelerator-Based Science, RIKEN, 2-1 Hirosawa, Wako, 351-0198 Saitama, Japan
| | - S Kawase
- Center for Nuclear Study, The University of Tokyo, 2-1 Hirosawa, Wako, 351-0198 Saitama, Japan
| | - T Kubo
- Nishina Center for Accelerator-Based Science, RIKEN, 2-1 Hirosawa, Wako, 351-0198 Saitama, Japan
| | - K Kusaka
- Nishina Center for Accelerator-Based Science, RIKEN, 2-1 Hirosawa, Wako, 351-0198 Saitama, Japan
| | - H Matsubara
- Center for Nuclear Study, The University of Tokyo, 2-1 Hirosawa, Wako, 351-0198 Saitama, Japan
| | - S Michimasa
- Center for Nuclear Study, The University of Tokyo, 2-1 Hirosawa, Wako, 351-0198 Saitama, Japan
| | - K Miki
- Department of Physics, School of Science, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, 113-0033 Tokyo, Japan
| | - G Mishima
- Department of Physics, School of Science, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, 113-0033 Tokyo, Japan
| | - H Miya
- Nishina Center for Accelerator-Based Science, RIKEN, 2-1 Hirosawa, Wako, 351-0198 Saitama, Japan
| | - H Nagahiro
- Department of Physics, Nara Women's University, Kita-Uoya Nishimachi, Nara, 630-8506 Nara, Japan
| | - M Nakamura
- Nishina Center for Accelerator-Based Science, RIKEN, 2-1 Hirosawa, Wako, 351-0198 Saitama, Japan
| | - S Noji
- Department of Physics, School of Science, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, 113-0033 Tokyo, Japan
| | - K Okochi
- Department of Physics, School of Science, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, 113-0033 Tokyo, Japan
| | - S Ota
- Center for Nuclear Study, The University of Tokyo, 2-1 Hirosawa, Wako, 351-0198 Saitama, Japan
| | - N Sakamoto
- Nishina Center for Accelerator-Based Science, RIKEN, 2-1 Hirosawa, Wako, 351-0198 Saitama, Japan
| | - K Suzuki
- Stefan Meyer Institute for Subatomic Physics, Austrian Academy of Sciences, Boltzmanngasse 3, A-1090 Vienna, Austria
| | - H Takeda
- Nishina Center for Accelerator-Based Science, RIKEN, 2-1 Hirosawa, Wako, 351-0198 Saitama, Japan
| | - Y K Tanaka
- Department of Physics, School of Science, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, 113-0033 Tokyo, Japan
| | - K Todoroki
- Department of Physics, School of Science, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, 113-0033 Tokyo, Japan
| | - K Tsukada
- Nishina Center for Accelerator-Based Science, RIKEN, 2-1 Hirosawa, Wako, 351-0198 Saitama, Japan
| | - T Uesaka
- Nishina Center for Accelerator-Based Science, RIKEN, 2-1 Hirosawa, Wako, 351-0198 Saitama, Japan
| | - Y N Watanabe
- Department of Physics, School of Science, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, 113-0033 Tokyo, Japan
| | - H Weick
- GSI Helmholtzzentrum für Schwerionenforschung GmbH, Planckstrasse 1, D-64291 Darmstadt, Germany
| | - H Yamakami
- Department of Physics, Kyoto University, Kitashirakawa-Oiwakecho, Sakyo-ku, Kyoto, 606-8502 Kyoto, Japan
| | - K Yoshida
- Nishina Center for Accelerator-Based Science, RIKEN, 2-1 Hirosawa, Wako, 351-0198 Saitama, Japan
| |
Collapse
|
26
|
Affiliation(s)
- Kazuhiro Kosugi
- Department of Palliative Care, Kawasaki Municipal Ida Hospital, Japan
| | - Tomohiro Nishi
- Department of Medical Oncology, Kawasaki Municipal Ida Hospital, Japan
| | - Tatsuyuki Iijima
- Department of Internal Medicine, Kawasaki Municipal Ida Hospital, Japan
| | | |
Collapse
|
27
|
Taki Y, Imai N, Nishi T, Shibagaki Y. Transarterial Embolization of a Ruptured Renal Angiomyolipoma. Intern Med 2018; 57:283-284. [PMID: 29021483 PMCID: PMC5820053 DOI: 10.2169/internalmedicine.9157-17] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/24/2022] Open
Affiliation(s)
- Yasuhiro Taki
- Department of Internal Medicine, St. Marianna University School of Medicine, Japan
| | - Naohiko Imai
- Department of Internal Medicine, St. Marianna University School of Medicine, Japan
| | - Tomohiro Nishi
- Department of Urology, St. Marianna University School of Medicine, Japan
| | - Yugo Shibagaki
- Department of Internal Medicine, St. Marianna University School of Medicine, Japan
| |
Collapse
|
28
|
Amano K, Maeda I, Morita T, Baba M, Miura T, Hama T, Mori I, Nakajima N, Nishi T, Sakurai H, Shimoyama S, Shinjo T, Shirayama H, Yamada T, Ono S, Ozawa T, Yamamoto R, Yamamoto N, Shishido H, Kinoshita H. C-reactive protein, symptoms and activity of daily living in patients with advanced cancer receiving palliative care. J Cachexia Sarcopenia Muscle 2017; 8:457-465. [PMID: 28247593 PMCID: PMC5476854 DOI: 10.1002/jcsm.12184] [Citation(s) in RCA: 45] [Impact Index Per Article: 6.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/18/2015] [Revised: 12/09/2016] [Accepted: 12/28/2016] [Indexed: 01/06/2023] Open
Abstract
BACKGROUND The association between C-reactive protein (CRP) level, symptoms, and activities of daily living (ADL) in advanced cancer patients is unclear. METHODS Secondary data analysis of a multicenter prospective cohort study consisted of 2426 advanced cancer patients referred to palliative care settings was conducted to examine the cross-sectional relationships between CRP level, symptoms, and ADL disabilities. Laboratory data, symptoms, ADL, and manual muscle testing (MMT) results were obtained at baseline. Participants were divided into four groups: low (CRP < 1 mg/dl), moderate (1 = < CRP <5 mg/dl), high (5 = < CRP < 10 mg/dl), and very high CRP (10 mg/dl = < CRP). The proportions of eight symptoms, five ADL disabilities, and three categories of MMT according to the CRP groups were tested by chi-square tests. Multiple-adjusted odd ratios (ORs) were calculated by using ordinal logistic regression after adjustment for age, gender, site of primary cancer, metastatic disease, performance status, chemotherapy, and setting of care. RESULTS A total of 1702 patients were analysed. Positive rates of symptoms and ADL disabilities increased with increasing CRP level. In the very high-CRP group, rates of positivity for anorexia, fatigue, and weight loss were 89.8%, 81.0%, and 79.2%, respectively, and over 70% of patients received assistance for bathing, dressing, going to the toilet, and transfer. The grade of MMT also deteriorated with increasing CRP level. Adjusted ORs for the accumulated symptoms significantly increased with increasing CRP level in the moderate-CRP, high-CRP, and very high-CRP groups [1.6 (95% confidence interval 1.2-2.0), P < 0.001; 2.5 (1.9-3.2), P < 0.001; 3.5 (2.7-4.6), P < 0.001, respectively]. Adjusted ORs for the accumulated ADL disabilities significantly increased in the very high-CRP groups [2.1 (1.5-2.9), P < 0.001]. CONCLUSIONS Associations between CRP level, symptoms, and ADL were observed in advanced cancer patients receiving palliative care.
Collapse
Affiliation(s)
- Koji Amano
- Department of Palliative Medicine, Osaka City General Hospital, 2-13-22 Miyakojima-hondori, Miyakojima-ku, Osaka City, 534-0021, Japan
| | - Isseki Maeda
- Department of Palliative Medicine, Graduate School of Medicine, Osaka University, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan
| | - Tatsuya Morita
- Palliative and Supportive Care Division, Seirei Mikatahara General Hospital, 3453 Mikatahara-cho, Kita-ku, Hamamatsu, Shizuoka, 433-8558, Japan
| | - Mika Baba
- Department of Palliative Care, Saito Yukoukai Hospital, 7-2-18 Saito Asagi, Ibaragi, Osaka, 567-0085, Japan
| | - Tomofumi Miura
- Department of Palliative Medicine, National Cancer Hospital East, 6-5-1 Kashiwanoha, Kashiwa, Chibay, 277-8577, Japan
| | - Takashi Hama
- Palliative Care Team, Osaka Medical Center for Cancer and Cardiovascular Diseases, 1-3-3 Nakamichi, Higashinari-ku, Osaka, 537-8511, Japan
| | - Ichiro Mori
- Gratia Hospital Hospice, 6-14-1 Aomadaninishi, Mino, Osaka, 562-8567, Japan
| | - Nobuhisa Nakajima
- Department of Palliative Medicine, Graduate School of Medicine, Tohoku University, 1-1 Seiryo-machi, Aobaku, Sendai, Miyagi, 980-8574, Japan
| | - Tomohiro Nishi
- Kawasaki Comprehensive Care Center, Kawasaki Municipal Ida Hospital, 2-27-1 Ida Nakahara-ku, Kawasaki, Kanagawa, 211-0035, Japan
| | - Hiroki Sakurai
- Department of Palliative Care, St. Luke's International Hospital, Tokyo, 9-1 Akashi-cho, Chuo-ku, Tokyo, 104-8560, Japan
| | - Satofumi Shimoyama
- Department of Palliative Care, Aichi Cancer Center Hospital, 1-1 Kanokoden, Chikusa-ku, Nagoya, Aichi, 464-8681, Japan
| | - Takuya Shinjo
- Shinjo Clinic, Kobe, 1-5-1-307 Kitagoyou, Kita-ku, Kobe, Hyogo, 651-1131, Japan
| | - Hiroto Shirayama
- Osaka Kita Homecare Clinic, Shin-Osaka 3rd Doi-biru 3F, 1-8-24 Nisimiyahara Yodogawa-ku, Osaka, 532-0004, Japan
| | - Takeshi Yamada
- Department of Gastrointestinal and Hepato-Biliary-Pancreatic Surgery, Nippon Medical School, 1-1-5 Sendagi, Bunkyo-ku, Tokyo, 113-8602, Japan
| | - Shigeki Ono
- Division of Palliative Medicine, Shizuoka Cancer Center Hospital, 1007 Shimonagakubo, Nagaizumi-cho, Suntou-gun, Shizuoka, 411-8777, Japan
| | - Taketoshi Ozawa
- Megumi Zaitaku Clinic, 2-4-3 Hashido, Seya-ku, Yokohama, Kanagawa, 246-0037, Japan
| | - Ryo Yamamoto
- Department of Palliative Medicine, Saku Central Hospital Advanced Care Center, 3400-28 Nakagomi, Saku, Nagano, 385-0051, Japan
| | - Naoki Yamamoto
- Department of Primary Care Service, Shinsei Hospital, 851 Obusechou, Kamitakai-gun, Nagano, 381-0295, Japan
| | - Hideki Shishido
- Shishido Internal Medicine Clinic, 1-18-7 Ojidai, Sakura, Chiba, 285-0837, Japan
| | - Hiroya Kinoshita
- Department of Palliative Medicine, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa, Chiba, 277-8577, Japan
| |
Collapse
|
29
|
Inagaki M, Ota D, Tsuji M, Nishi T, Kato T, Kobayashi Y, Mori M, Fukuuchi A. T2-weighted magnetic resonance images of triple negative breast cancer with high tumor infiltrating lymphocytes. Breast 2017. [DOI: 10.1016/s0960-9776(17)30193-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022] Open
|
30
|
Matsuo N, Morita T, Matsuda Y, Okamoto K, Matsumoto Y, Kaneishi K, Odagiri T, Sakurai H, Katayama H, Mori I, Yamada H, Watanabe H, Yokoyama T, Yamaguchi T, Nishi T, Shirado A, Hiramoto S, Watanabe T, Kohara H, Shimoyama S, Aruga E, Baba M, Sumita K, Iwase S. Predictors of Delirium in Corticosteroid-Treated Patients with Advanced Cancer: An Exploratory, Multicenter, Prospective, Observational Study. J Palliat Med 2017; 20:352-359. [PMID: 28379811 DOI: 10.1089/jpm.2016.0323] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
BACKGROUND Corticosteroids are often used to treat fatigue and anorexia, but occasionally produce delirium. Information on the predictors of delirium in corticosteroid-treated cancer patients remains limited. OBJECTIVE To identify potential factors predicting the development of delirium in corticosteroid-treated cancer patients. DESIGN An exploratory, multicenter, prospective, observational study. SETTING/SUBJECTS Inclusion criteria for this study were patients who had metastatic or locally advanced cancer and a fatigue or anorexia intensity score of 4 or more on a 0-10 Numerical Rating Scale. MEASUREMENT Univariate and multivariable analyses were performed to identify the predictors of delirium diagnosed by the Confusion Assessment Method (CAM) within three days of initiation of corticosteroids. RESULTS Among 207 patients administered corticosteroids, 35 (17%; 95% confidence interval [CI] 12%-23%) developed at least one episode of delirium diagnosed by the CAM. Factors predictive of the development of delirium were as follows: Palliative Performance Scale ≤20, Eastern Cooperative Oncology Group Performance Status (ECOG PS) = 4, the Support Team Assessment Schedule (STAS) score of drowsiness >1, concurrent opioid use, parenteral hydration volume ≤500 mL, and the absence of lung metastasis. A multivariable analysis identified the independent factors predicting responses as ECOG PS = 4 (odds ratio [OR] 4.0; 95% CI 1.7-9.3), STAS score of drowsiness >1 (OR 3.4; 95% CI 1.4-8.2), and concurrent opioid use (OR 3.7; 95% CI 1.0-13). CONCLUSION Delirium in corticosteroid-treated advanced cancer patients may be predicted by PS, drowsiness, and concurrent opioid use. Larger prospective studies are needed to confirm these results.
Collapse
Affiliation(s)
- Naoki Matsuo
- 1 Hospice, Medical Corporation Junkei-kai Sotoasahikawa Hospital , Akita, Japan
| | - Tatsuya Morita
- 2 Palliative and Supportive care Division, Seirei Mikatahara General Hospital , Hamamatsu, Japan
| | - Yoshinobu Matsuda
- 3 Department of Psychosomatic Internal Medicine, National Hospital, Organization Kinki-Chuo Chest Medical Center , Sakai, Japan
| | - Kenichiro Okamoto
- 4 Palliative Medicine, Showa University Northern Yokohama Hospital , Yokohama, Japan
| | - Yoshihisa Matsumoto
- 5 Department of Palliative Medicine, National Cancer Center Hospital East , Kashiwa, Japan
| | - Keisuke Kaneishi
- 6 Department of Palliative Care Unit, JCHO Tokyo Shinjuku Medical Center , Tokyo, Japan
| | | | - Hiroki Sakurai
- 8 Department of Palliative Care and Pain Management, Cancer Institute Hospital , Tokyo, Japan
| | | | | | | | | | - Taro Yokoyama
- 12 Department of Palliative Medicine, Yokohama Municipal Citizens Hospital , Yokohama, Japan
| | - Takashi Yamaguchi
- 13 Department of Palliative Medicine, Kobe University Graduate School of Medicine , Kobe, Japan
| | | | - Akemi Shirado
- 15 Seirei Mikatahara General Hospital , Hamamatsu, Japan
| | - Shuji Hiramoto
- 16 Department of Oncology, Mitsubishi Kyoto Hospital , Kyoto, Japan
| | | | - Hiroyuki Kohara
- 18 Department of Palliative Care, Hiroshima Prefectural Hospital , Hiroshima, Japan
| | - Satofumi Shimoyama
- 19 Department of Palliative Care, Aichi Cancer Center Hospital , Nagoya, Japan
| | - Etsuko Aruga
- 20 Department of Palliative medicine, Teikyo University School of Medicine , Tokyo, Japan
| | - Mika Baba
- 21 Palliative care Division, Saito Yukoukai Hospital , Osaka, Japan
| | | | - Satoru Iwase
- 23 Research Hospital, The Institute of Medical Science, The University of Tokyo , Tokyo, Japan
| |
Collapse
|
31
|
Tanaka YK, Itahashi K, Fujioka H, Ayyad Y, Benlliure J, Brinkmann KT, Friedrich S, Geissel H, Gellanki J, Guo C, Gutz E, Haettner E, Harakeh MN, Hayano RS, Higashi Y, Hirenzaki S, Hornung C, Igarashi Y, Ikeno N, Iwasaki M, Jido D, Kalantar-Nayestanaki N, Kanungo R, Knöbel R, Kurz N, Metag V, Mukha I, Nagae T, Nagahiro H, Nanova M, Nishi T, Ong HJ, Pietri S, Prochazka A, Rappold C, Reiter MP, Rodríguez-Sánchez JL, Scheidenberger C, Simon H, Sitar B, Strmen P, Sun B, Suzuki K, Szarka I, Takechi M, Tanihata I, Terashima S, Watanabe YN, Weick H, Widmann E, Winfield JS, Xu X, Yamakami H, Zhao J. Measurement of Excitation Spectra in the ^{12}C(p,d) Reaction near the η^{'} Emission Threshold. Phys Rev Lett 2016; 117:202501. [PMID: 27886506 DOI: 10.1103/physrevlett.117.202501] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/11/2016] [Indexed: 06/06/2023]
Abstract
Excitation spectra of ^{11}C are measured in the ^{12}C(p,d) reaction near the η^{'} emission threshold. A proton beam extracted from the synchrotron SIS-18 at GSI with an incident energy of 2.5 GeV impinges on a carbon target. The momenta of deuterons emitted at 0° are precisely measured with the fragment separator (FRS) operated as a spectrometer. In contrast to theoretical predictions on the possible existence of deeply bound η^{'}-mesic states in carbon nuclei, no distinct structures are observed associated with the formation of bound states. The spectra are analyzed to set stringent constraints on the formation cross section and on the hitherto barely known η^{'}-nucleus interaction.
Collapse
Affiliation(s)
- Y K Tanaka
- The University of Tokyo, 7-3-1 Hongo, Bunkyo, 113-0033 Tokyo, Japan
| | - K Itahashi
- Nishina Center for Accelerator-Based Science, RIKEN, 2-1 Hirosawa, Wako, 351-0198 Saitama, Japan
| | - H Fujioka
- Kyoto University, Kitashirakawa-Oiwakecho, Sakyo-ku, 606-8502 Kyoto, Japan
| | - Y Ayyad
- RCNP, Osaka University, 10-1 Mihogaoka, Ibaraki, 567-0047 Osaka, Japan
| | - J Benlliure
- Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain
| | - K-T Brinkmann
- Universität Giessen, Heinrich-Buff-Ring 16, 35392 Giessen, Germany
| | - S Friedrich
- Universität Giessen, Heinrich-Buff-Ring 16, 35392 Giessen, Germany
| | - H Geissel
- Universität Giessen, Heinrich-Buff-Ring 16, 35392 Giessen, Germany
- GSI Helmholtzzentrum für Schwerionenforschung GmbH, Planckstraße 1, 64291 Darmstadt, Germany
| | - J Gellanki
- KVI-CART, University of Groningen, Zernikelaan 25, 9747 AA Groningen, The Netherlands
| | - C Guo
- Beihang University, Xueyuan Road 37, Haidian District, 100191 Beijing, China
| | - E Gutz
- Universität Giessen, Heinrich-Buff-Ring 16, 35392 Giessen, Germany
| | - E Haettner
- GSI Helmholtzzentrum für Schwerionenforschung GmbH, Planckstraße 1, 64291 Darmstadt, Germany
| | - M N Harakeh
- KVI-CART, University of Groningen, Zernikelaan 25, 9747 AA Groningen, The Netherlands
| | - R S Hayano
- The University of Tokyo, 7-3-1 Hongo, Bunkyo, 113-0033 Tokyo, Japan
| | - Y Higashi
- Nara Women's University, Kita-Uoya Nishi-Machi, 630-8506 Nara, Japan
| | - S Hirenzaki
- Nara Women's University, Kita-Uoya Nishi-Machi, 630-8506 Nara, Japan
| | - C Hornung
- Universität Giessen, Heinrich-Buff-Ring 16, 35392 Giessen, Germany
| | - Y Igarashi
- KEK, 1-1 Oho, Tsukuba, 305-0801 Ibaraki, Japan
| | - N Ikeno
- Tottori University, 4-101 Koyamacho-minami, 680-8551 Tottori, Japan
| | - M Iwasaki
- Nishina Center for Accelerator-Based Science, RIKEN, 2-1 Hirosawa, Wako, 351-0198 Saitama, Japan
| | - D Jido
- Tokyo Metropolitan University, 1-1 Minami-Osawa, Hachioji, 192-0397 Tokyo, Japan
| | | | - R Kanungo
- Saint Mary's University, 923 Robie Street, Halifax, Nova Scotia B3H 3C3, Canada
| | - R Knöbel
- Universität Giessen, Heinrich-Buff-Ring 16, 35392 Giessen, Germany
- GSI Helmholtzzentrum für Schwerionenforschung GmbH, Planckstraße 1, 64291 Darmstadt, Germany
| | - N Kurz
- GSI Helmholtzzentrum für Schwerionenforschung GmbH, Planckstraße 1, 64291 Darmstadt, Germany
| | - V Metag
- Universität Giessen, Heinrich-Buff-Ring 16, 35392 Giessen, Germany
| | - I Mukha
- GSI Helmholtzzentrum für Schwerionenforschung GmbH, Planckstraße 1, 64291 Darmstadt, Germany
| | - T Nagae
- Kyoto University, Kitashirakawa-Oiwakecho, Sakyo-ku, 606-8502 Kyoto, Japan
| | - H Nagahiro
- Nara Women's University, Kita-Uoya Nishi-Machi, 630-8506 Nara, Japan
| | - M Nanova
- Universität Giessen, Heinrich-Buff-Ring 16, 35392 Giessen, Germany
| | - T Nishi
- Nishina Center for Accelerator-Based Science, RIKEN, 2-1 Hirosawa, Wako, 351-0198 Saitama, Japan
| | - H J Ong
- RCNP, Osaka University, 10-1 Mihogaoka, Ibaraki, 567-0047 Osaka, Japan
| | - S Pietri
- GSI Helmholtzzentrum für Schwerionenforschung GmbH, Planckstraße 1, 64291 Darmstadt, Germany
| | - A Prochazka
- GSI Helmholtzzentrum für Schwerionenforschung GmbH, Planckstraße 1, 64291 Darmstadt, Germany
| | - C Rappold
- GSI Helmholtzzentrum für Schwerionenforschung GmbH, Planckstraße 1, 64291 Darmstadt, Germany
| | - M P Reiter
- GSI Helmholtzzentrum für Schwerionenforschung GmbH, Planckstraße 1, 64291 Darmstadt, Germany
| | | | - C Scheidenberger
- Universität Giessen, Heinrich-Buff-Ring 16, 35392 Giessen, Germany
- GSI Helmholtzzentrum für Schwerionenforschung GmbH, Planckstraße 1, 64291 Darmstadt, Germany
| | - H Simon
- GSI Helmholtzzentrum für Schwerionenforschung GmbH, Planckstraße 1, 64291 Darmstadt, Germany
| | - B Sitar
- Comenius University Bratislava, Mlynská dolina, 842 48 Bratislava, Slovakia
| | - P Strmen
- Comenius University Bratislava, Mlynská dolina, 842 48 Bratislava, Slovakia
| | - B Sun
- Beihang University, Xueyuan Road 37, Haidian District, 100191 Beijing, China
| | - K Suzuki
- Stefan-Meyer-Institut für subatomare Physik, Boltzmangasse 3, 1090 Vienna, Austria
| | - I Szarka
- Comenius University Bratislava, Mlynská dolina, 842 48 Bratislava, Slovakia
| | - M Takechi
- Niigata University, 8050 Ikarashi 2-no-cho, Nishi-ku, 950-2181 Niigata, Japan
| | - I Tanihata
- RCNP, Osaka University, 10-1 Mihogaoka, Ibaraki, 567-0047 Osaka, Japan
- Beihang University, Xueyuan Road 37, Haidian District, 100191 Beijing, China
| | - S Terashima
- Beihang University, Xueyuan Road 37, Haidian District, 100191 Beijing, China
| | - Y N Watanabe
- The University of Tokyo, 7-3-1 Hongo, Bunkyo, 113-0033 Tokyo, Japan
| | - H Weick
- GSI Helmholtzzentrum für Schwerionenforschung GmbH, Planckstraße 1, 64291 Darmstadt, Germany
| | - E Widmann
- Stefan-Meyer-Institut für subatomare Physik, Boltzmangasse 3, 1090 Vienna, Austria
| | - J S Winfield
- GSI Helmholtzzentrum für Schwerionenforschung GmbH, Planckstraße 1, 64291 Darmstadt, Germany
| | - X Xu
- Universität Giessen, Heinrich-Buff-Ring 16, 35392 Giessen, Germany
- GSI Helmholtzzentrum für Schwerionenforschung GmbH, Planckstraße 1, 64291 Darmstadt, Germany
| | - H Yamakami
- Kyoto University, Kitashirakawa-Oiwakecho, Sakyo-ku, 606-8502 Kyoto, Japan
| | - J Zhao
- Beihang University, Xueyuan Road 37, Haidian District, 100191 Beijing, China
| |
Collapse
|
32
|
Matsuo N, Morita T, Matsuda Y, Okamoto K, Matsumoto Y, Kaneishi K, Odagiri T, Sakurai H, Katayama H, Mori I, Yamada H, Watanabe H, Yokoyama T, Yamaguchi T, Nishi T, Shirado A, Hiramoto S, Watanabe T, Kohara H, Shimoyama S, Aruga E, Baba M, Sumita K, Iwase S. Predictors of responses to corticosteroids for anorexia in advanced cancer patients: a multicenter prospective observational study. Support Care Cancer 2016; 25:41-50. [PMID: 27539132 DOI: 10.1007/s00520-016-3383-z] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/02/2016] [Accepted: 08/08/2016] [Indexed: 11/25/2022]
Abstract
PURPOSE Although corticosteroids are widely used to relieve anorexia, information regarding the factors predicting responses to corticosteroids remains limited. The purpose of the study is to identify potential factors predicting responses to corticosteroids for anorexia in advanced cancer patients. METHODS Inclusion criteria for this multicenter prospective observational study were patients who had metastatic or locally advanced cancer and had an anorexia intensity score of 4 or more on a 0-10 Numerical Rating Scale (NRS). Univariate and multivariate analyses were conducted to identify the factors predicting ≥2-point reduction in NRS on day 3. RESULTS Among 180 patients who received corticosteroids, 99 (55 %; 95 % confidence interval [CI], 47-62 %) had a response with ≥2-point reduction. Factors that significantly predicted responses were Palliative Performance Scale (PPS) > 40 and absence of drowsiness. In addition, factors that tended to be associated with ≥2-point reduction in NRS included PS 0-3, absence of diabetes mellitus, absence of peripheral edema, presence of lung metastasis, absence of peritoneal metastasis, baseline anorexia NRS of >6, presence of pain, and presence of constipation. A multivariate analysis showed that the independent factors predicting responses were PPS of >40 (odds ratio = 2.7 [95 % CI = 1.4-5.2]), absence of drowsiness (2.6 [1.3-5.0]), and baseline NRS of >6 (2.4 [1.1-4.8]). CONCLUSIONS Treatment responses to corticosteroids for anorexia may be predicted by PPS, drowsiness, and baseline symptom intensity. Larger prospective studies are needed to confirm these results.
Collapse
Affiliation(s)
- Naoki Matsuo
- Hospice, Medical Corporation Junkei-kai Sotoasahikawa Hospital, 42, Aza-Sangoden, Sotoasahikawa, Akita, Akita, 010-0802, Japan.
| | - Tatsuya Morita
- Palliative and Supportive care Division, Seirei Mikatahara General Hospital, 3453 Mikatahara-cho, Kita-ku, Hamamatsu, Shizuoka, 433-8558, Japan
| | - Yoshinobu Matsuda
- Department of Psychosomatic Internal Medicine, National Hospital, Organization Kinki-Chuo Chest Medical Center, Sakai City, Osaka, 591-8555, Japan
| | - Kenichiro Okamoto
- Palliative Medicine, Showa University Northern Yokohama Hospital, 35-1 Chigasaki Chuo Tsuduki-ku, Yokohama, Kanagawa, 224-8503, Japan
| | - Yoshihisa Matsumoto
- Department of Palliative Medicine, National Cancer Center Hospital East, 6-5-1, Kashiwanoha, Kashiwa, Chiba, 277-8577, Japan
| | - Keisuke Kaneishi
- Department of Palliative Care Unit, JCHO Tokyo Shinjuku Medical Center, 5-1 Tsukudo-cho, Shinjuku, Tokyo, 162-0815, Japan
| | - Takuya Odagiri
- Komaki City Hospital, 1-20 Jobushi, Komaki-city, Aichi, 485-8520, Japan
| | - Hiroki Sakurai
- Department of Palliative Care and Pain Management, Cancer Institute Hospital, 3-8-31 Ariake, Koto-ku, Tokyo, 135-8550, Japan
| | - Hideki Katayama
- NHO Yamaguchi-Ube Medical Center, 685, Higashi-Kiwa, Ube, Yamaguchi, 755-0241, Japan
| | - Ichiro Mori
- Gratia Hospital Hospice, 6-14-1 Aomadaninishi, Mino, Osaka, 562-8567, Japan
| | - Hirohide Yamada
- Seirei Hamamatsu General Hospital, 2-12-12 Sumiyoshi Naka-ku, Hamamatsu, Shizuoka, 430-8558, Japan
| | - Hiroaki Watanabe
- Komaki City Hospital, 1-20 Jobushi, Komaki, Aichi, 485-8520, Japan
| | - Taro Yokoyama
- Department of Palliative Medicine, Yokohama Municipal Citizens Hospital, 56, Okazawa-cho, Hodogaya-ku, Yokohama, Kanagawa, 240-8555, Japan
| | - Takashi Yamaguchi
- Department of Palliative Medicine, Kobe University Graduate School of Medicine, 7-5-1, Kusunokicho, Chuo-ku, Kobe, Hyogo, 650-0017, Japan
| | - Tomohiro Nishi
- Kawasaki Municipal Ida Hospital, Nakahara-ku Ida, Kawasaki, Kanagawa, 2-27-1, Japan
| | - Akemi Shirado
- Seirei Mikatahara General Hospital, 3453, Mikatahara-Cho, Kita-Ku, Hamamatsu, Shizuoka, 433-8558, Japan
| | - Shuji Hiramoto
- Department of Oncology, Mitsubishi Kyoto Hospital, Katsura Goshocho1, Nisikyo-ku, Kyoto, 615-8087, Japan
| | - Toshio Watanabe
- Toyama Prefectural Central Hospital, 2-2-78, Nishinagae, Toyama, Toyama, 930-8550, Japan
| | - Hiroyuki Kohara
- Department of Palliative Care, Hiroshima Prefectural Hospital, 1-5-54, Ujina-kanda, Minami-ku, Hiroshima, 734-8530, Japan
| | - Satofumi Shimoyama
- Department of Palliative Care, Aichi Cancer Center Hospital, 1-1, Kanokoden, Chikusa-ku, Nagoya, 464-8681, Japan
| | - Etsuko Aruga
- Department of Palliative Medicine, Teikyo University School of Medicine, 2-11-1, Kaga, Itabashi-ku, Tokyo, 173-8605, Japan
| | - Mika Baba
- Palliative Care Division, Saito Yukoukai Hospital, 7-2-18 Saito Asagi, Ibaragi, Osaka, 567-0085, Japan
| | - Koki Sumita
- Matsue City Hospital, 32-1, Noshira-cho, Matsue, Shimane, 690-8509, Japan
| | - Satoru Iwase
- Research Hospital, The Institute of Medical Science, The University of Tokyo, 4-6-1, Shirokanedai, Minato-ku, Tokyo, 108-8639, Japan
| |
Collapse
|
33
|
Mori Y, Nishimura Y, Hanayama R, Nakayama S, Ishii K, Kitagawa Y, Sekine T, Sato N, Kurita T, Kawashima T, Kan H, Komeda O, Nishi T, Azuma H, Hioki T, Motohiro T, Sunahara A, Sentoku Y, Miura E. Fast Heating of Imploded Core with Counterbeam Configuration. Phys Rev Lett 2016; 117:055001. [PMID: 27517775 DOI: 10.1103/physrevlett.117.055001] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/08/2016] [Indexed: 06/06/2023]
Abstract
A tailored-pulse-imploded core with a diameter of 70 μm is flashed by counterirradiating 110 fs, 7 TW laser pulses. Photon emission (>40 eV) from the core exceeds the emission from the imploded core by 6 times, even though the heating pulse energies are only one seventh of the implosion energy. The coupling efficiency from the heating laser to the core using counterirradiation is 14% from the enhancement of photon emission. Neutrons are also produced by counterpropagating fast deuterons accelerated by the photon pressure of the heating pulses. A collisional two-dimensional particle-in-cell simulation reveals that the collisionless two counterpropagating fast-electron currents induce mega-Gauss magnetic filaments in the center of the core due to the Weibel instability. The counterpropagating fast-electron currents are absolutely unstable and independent of the core density and resistivity. Fast electrons with energy below a few MeV are trapped by these filaments in the core region, inducing an additional coupling. This might lead to the observed bright photon emissions.
Collapse
Affiliation(s)
- Y Mori
- The Graduate School for the Creation of New Photonics Industries, 1955-1 Kurematsuchou, Nishi-ku, Hamamatsu 431-1202, Japan
| | - Y Nishimura
- The Graduate School for the Creation of New Photonics Industries, 1955-1 Kurematsuchou, Nishi-ku, Hamamatsu 431-1202, Japan
| | - R Hanayama
- The Graduate School for the Creation of New Photonics Industries, 1955-1 Kurematsuchou, Nishi-ku, Hamamatsu 431-1202, Japan
| | - S Nakayama
- The Graduate School for the Creation of New Photonics Industries, 1955-1 Kurematsuchou, Nishi-ku, Hamamatsu 431-1202, Japan
| | - K Ishii
- The Graduate School for the Creation of New Photonics Industries, 1955-1 Kurematsuchou, Nishi-ku, Hamamatsu 431-1202, Japan
| | - Y Kitagawa
- The Graduate School for the Creation of New Photonics Industries, 1955-1 Kurematsuchou, Nishi-ku, Hamamatsu 431-1202, Japan
| | - T Sekine
- Hamamatsu Photonics, K. K. 1820 Kurematsuchou, Nishi-ku, Hamamatsu 431-1202, Japan
| | - N Sato
- Hamamatsu Photonics, K. K. 1820 Kurematsuchou, Nishi-ku, Hamamatsu 431-1202, Japan
| | - T Kurita
- Hamamatsu Photonics, K. K. 1820 Kurematsuchou, Nishi-ku, Hamamatsu 431-1202, Japan
| | - T Kawashima
- Hamamatsu Photonics, K. K. 1820 Kurematsuchou, Nishi-ku, Hamamatsu 431-1202, Japan
| | - H Kan
- Hamamatsu Photonics, K. K. 1820 Kurematsuchou, Nishi-ku, Hamamatsu 431-1202, Japan
| | - O Komeda
- Advanced Material Engineering Division, Toyota Motor Corporation, 1200 Mishuku, Susono, Shizuoka 410-1193, Japan
| | - T Nishi
- Toyota Central Research and Development Laboratories, Inc., 41-1 Yokomichi, Nagakute, Aichi 480-1192, Japan
| | - H Azuma
- Aichi Synchrotron Radiation Center, Minamiyamaguchi-cho, Seto-shi, Aichi-ken 489-0965, Japan
| | - T Hioki
- Green Mobility Collaborative Research Center, Nagoya University, Furo-cho, Chikusa-ku, Nagoya 464-8601, Japan
| | - T Motohiro
- Green Mobility Collaborative Research Center, Nagoya University, Furo-cho, Chikusa-ku, Nagoya 464-8601, Japan
| | - A Sunahara
- Institute for Laser Technology, 1-8-4 Utsubo-honmachi, Nishi-ku, Osaka 550-0004, Japan
| | - Y Sentoku
- Department of Physics, University of Nevada, Reno, 1664 North Virginia Street, Reno, Nevada 89557, USA
| | - E Miura
- National Institute of Advanced Industrial Science and Technology, 1-1-1 Umezono, Tsukuba, Ibaraki 305-8568, Japan
| |
Collapse
|
34
|
Mori M, Nishi T, Nozato J, Matsumoto Y, Miyamoto S, Kizawa Y, Morita T. Unmet Learning Needs of Physicians in Specialty Training in Palliative Care: A Japanese Nationwide Study. J Palliat Med 2016; 19:1074-1079. [PMID: 27386741 DOI: 10.1089/jpm.2015.0166] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
BACKGROUND Despite the urgent need for a quality training system in palliative care, learning needs among physicians in palliative care specialty training have not been systematically explored in Japan. AIM To clarify unmet learning needs among Japanese physicians in specialty training in palliative care and the potential solutions they favor to meet those needs. DESIGN A Japanese nationwide survey. SETTING/PARTICIPANTS Participants were physicians in specialty training in palliative care. The questionnaire included unmet learning needs and potential solutions. Factor analysis was performed to identify underlying subscales of unmet needs. RESULTS In total, 253 of 735 institutions (34%) responded; of 284 physicians, 253 (89%) responded and 229 were eligible. The most prevalent unmet needs included the following: "to learn areas other than medicine" (89%), "to obtain research support from a data center" (87%), and "to learn ways to educate students and residents about palliative medicine" (87%). The potential solutions most participants favored to meet those needs included the following: "to develop a comprehensive training program" (74%), "to develop systems which reflect trainees' opinions on the improvement of training programs" (71%), and "to increase the number of training institutions" (69%). CONCLUSION Physicians in palliative care specialty training had markedly unmet needs regarding training on comprehensive contents, education, and research support; they considered increasing the number of comprehensive quality training programs as a potential solution. Our findings may help physicians in palliative care training, faculty physicians, training programs, academic societies, and the government to develop collaborative efforts to fulfill the unmet needs of trainees.
Collapse
Affiliation(s)
- Masanori Mori
- 1 Department of Palliative Medicine, Seirei Hamamatsu General Hospital , Hamamatsu, Japan
| | - Tomohiro Nishi
- 2 Kawasaki Comprehensive Care Center , Kawasaki Municipal Ida Hospital, Kawasaki, Japan
| | - Junko Nozato
- 1 Department of Palliative Medicine, Seirei Hamamatsu General Hospital , Hamamatsu, Japan
| | - Yoshihisa Matsumoto
- 3 Department of Palliative Medicine, National Cancer Center Hospital East , Kashiwa, Japan
| | - Shingo Miyamoto
- 4 Department of Oncology, Japanese Red Cross Medical Center , Tokyo, Japan
| | - Yoshiyuki Kizawa
- 5 Department of Palliative Medicine, Kobe University Graduate School of Medicine , Kobe, Japan
| | - Tatsuya Morita
- 6 Palliative and Supportive Care Division, Seirei Mikatahara General Hospital , Hamamatsu, Japan
| |
Collapse
|
35
|
Matsuo N, Morita T, Matsuda Y, Okamoto K, Matsumoto Y, Kaneishi K, Odagiri T, Sakurai H, Katayama H, Mori I, Yamada H, Watanabe H, Yokoyama T, Yamaguchi T, Nishi T, Shirado A, Hiramoto S, Watanabe T, Kohara H, Shimoyama S, Aruga E, Baba M, Sumita K, Iwase S. Predictors of Responses to Corticosteroids for Cancer-Related Fatigue in Advanced Cancer Patients: A Multicenter, Prospective, Observational Study. J Pain Symptom Manage 2016; 52:64-72. [PMID: 27233138 DOI: 10.1016/j.jpainsymman.2016.01.015] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/02/2015] [Revised: 01/14/2016] [Accepted: 02/13/2016] [Indexed: 01/08/2023]
Abstract
CONTEXT Although corticosteroids are widely used to relieve cancer-related fatigue (CRF), information regarding the factors predicting responses to corticosteroids remains limited. OBJECTIVES The aim of this study was to identify potential factors predicting responses to corticosteroids for CRF in advanced cancer patients. METHODS Inclusion criteria for this multicenter, prospective, observational study were patients who had metastatic or locally advanced cancer and had a fatigue intensity score of 4 or more on a 0-10 Numerical Rating Scale (NRS). Univariate and multivariate analyses were conducted to identify the factors predicting two-point reduction or more in NRS on day 3. RESULTS Among 179 patients who received corticosteroids, 86 (48%; 95% CI 41%-56%) had a response with two-point reduction or more. Factors that significantly predicted responses were performance status score of 3 or more, Palliative Performance Scale score more than 40, absence of ascites, absence of drowsiness, absence of depression, serum albumin level greater than 3 mg/dL, serum sodium level greater than 135 mEq/L, and baseline NRS score greater than 5. A multivariate analysis showed that the independent factors predicting responses were baseline NRS score greater than 5 (odds ratio [OR] 6.6, 95% CI 2.8-15.4), Palliative Performance Scale score more than 40 (OR 4.4, 95% CI 2.1-9.3), absence of drowsiness (OR 3.4, 95% CI 1.7-6.9), absence of ascites (OR 2.3, 95% CI 1.1-4.7), and absence of pleural effusion (OR 2.2, 95% CI 1.0-5.0). CONCLUSION Treatment responses to corticosteroids for CRF may be predicted by baseline symptom intensity, performance status, drowsiness, and severity of fluid retention symptoms. Larger prospective studies are needed to confirm these results.
Collapse
Affiliation(s)
- Naoki Matsuo
- Hospice, Medical Corporation Junkei-kai Sotoasahikawa Hospital, Sotoasahikawa, Akita, Akita, Japan.
| | - Tatsuya Morita
- Palliative and Supportive Care Division, Seirei Mikatahara General Hospital, Hamamatsu, Shizuoka, Japan
| | - Yoshinobu Matsuda
- Department of Psychosomatic Internal Medicine, National Hospital Organization Kinki-Chuo Chest Medical Center, Sakai City, Osaka, Japan
| | - Kenichiro Okamoto
- Palliative Medicine, Showa University Northern Yokohama Hospital, Yokohama, Kanagawa, Japan
| | - Yoshihisa Matsumoto
- Department of Palliative Medicine, National Cancer Center Hospital East, Kashiwa, Chiba, Japan
| | - Keisuke Kaneishi
- Department of Palliative Care Unit, JCHO Tokyo Shinjuku Medical Center, Shinjuku, Tokyo, Japan
| | | | - Hiroki Sakurai
- Department of Palliative Care and Pain Management, Cancer Institute Hospital, Koto-ku, Tokyo, Japan
| | | | | | - Hirohide Yamada
- Seirei Hamamatsu General Hospital, Hamamatsu, Shizuoka, Japan
| | | | - Taro Yokoyama
- Department of Palliative Medicine, Yokohama Municipal Citizens Hospital, Yokohama, Kanagawa, Japan
| | - Takashi Yamaguchi
- Department of Palliative Medicine, Kobe University Graduate School of Medicine, Kobe, Hyogo, Japan
| | - Tomohiro Nishi
- Kawasaki Municipal Ida Hospital, Kawasaki, Kanagawa, Japan
| | - Akemi Shirado
- Seirei Hamamatsu General Hospital, Hamamatsu, Shizuoka, Japan
| | - Shuji Hiramoto
- Department of Oncology, Mitsubishi Kyoto Hospital, Nisikyo-ku, Kyoto, Japan
| | | | - Hiroyuki Kohara
- Department of Palliative Care, Hiroshima Prefectural Hospital, Minami-ku, Hiroshima, Japan
| | - Satofumi Shimoyama
- Department of Palliative Care, Aichi Cancer Center Hospital, Chikusa-ku, Nagoya, Japan
| | - Etsuko Aruga
- Department of Palliative Medicine, Teikyo University School of Medicine, Itabashi-ku, Tokyo, Japan
| | - Mika Baba
- Palliative Care Division, Saito Yukoukai Hospital, Ibaragi, Osaka, Japan
| | - Koki Sumita
- Matsue City Hospital, Matsue, Shimane, Japan
| | - Satoru Iwase
- Research Hospital, The Institute of Medical Science, The University of Tokyo, Minato-ku, Tokyo, Japan
| |
Collapse
|
36
|
Yamaguchi T, Goya S, Kohara H, Watanabe H, Mori M, Matsuda Y, Nakamura Y, Sakashita A, Nishi T, Tanaka K. Treatment Recommendations for Respiratory Symptoms in Cancer Patients: Clinical Guidelines from the Japanese Society for Palliative Medicine. J Palliat Med 2016; 19:925-35. [PMID: 27315488 DOI: 10.1089/jpm.2016.0145] [Citation(s) in RCA: 31] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/02/2023] Open
Abstract
BACKGROUND Respiratory symptoms, dyspnea, cough, and death rattle, are common and distressing in advanced cancer patients. Palliation of respiratory symptoms is important to improve quality of life in cancer patients and their families/caregivers. Currently published clinical guidelines for the management of these respiratory symptoms in cancer patients did not cover the topics comprehensively or were not based on formal process for the development of clinical guidelines. METHODS The Japanese Society for Palliative Medicine (JSPM) decided to develop comprehensive clinical guidelines for the management of respiratory symptoms in cancer patients following the formal guideline developing process. RESULTS This article provides a summary of the recommendations with the rationales, as well as a short summary of the developing process, of the JSPM respiratory symptom management guidelines. We established 26 recommendations and all recommendations are based on the best available evidences and expert consensus. DISCUSSION More future clinical researches and continuous guideline updates are required to improve the quality of respiratory symptom management in cancer patients.
Collapse
Affiliation(s)
- Takashi Yamaguchi
- 1 Department of Palliative Medicine, Kobe University Graduate School of Medicine , Kobe, Japan
| | - Sho Goya
- 2 Department of Respiratory Medicine, Kinki Central Hospital , Itami, Japan
| | - Hiroyuki Kohara
- 3 Department of Palliative Medicine, Hiroshima Prefectural Hospital , Hiroshima, Japan
| | - Hiroaki Watanabe
- 4 Department of Palliative Medicine, Komaki Municipal Hospital , Komaki, Japan
| | - Masanori Mori
- 5 Department of Palliative Medicine, Seirei Hamamatsu General Hospital , Hamamatsu, Japan
| | - Yoshinobu Matsuda
- 6 Department of Psycho-somatic Medicine, Kinki-Chuo Chest Medical Center , Sakai, Japan
| | - Yoichi Nakamura
- 7 Department of Surgery, Toho University Ohashi Medical Center , Tokyo, Japan
| | - Akihiro Sakashita
- 8 Department of Palliative Care, Hyogo Prefectural Kakogawa Medical Center , Kakogawa, Japan
| | - Tomohiro Nishi
- 9 Department of Medical Oncology, Kawasaki Municipal Ida Hospital , Kawasaki, Japan
| | - Keiko Tanaka
- 10 Department of Palliative Care, Tokyo Metropolitan Komagome Hospital , Tokyo, Japan
| |
Collapse
|
37
|
Nishi T, Hamamoto Y, Nagase M, Denda T, Yamaguchi K, Amagai K, Miyata Y, Yamanaka Y, Yanai K, Ishikawa T, Kuroki Y, Fujii H. Phase II trial of panitumumab with irinotecan as salvage therapy for patients with advanced or recurrent colorectal cancer (TOPIC study). Oncol Lett 2016; 11:4049-4054. [PMID: 27313739 DOI: 10.3892/ol.2016.4532] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/16/2015] [Accepted: 04/01/2016] [Indexed: 12/19/2022] Open
Abstract
Little is known about the clinical impact of salvage panitumumab with irinotecan for metastatic colorectal cancer (mCRC) patients. The present study conducted a single-arm, multicenter phase II trial for mCRC with skin toxicity prevention program. The subjects were mCRC patients with wild-type KRAS, who showed resistance to fluoropyrimidine, oxaliplatin and irinotecan. Panitumumab was administered at a dose of 6 mg/kg every 2 weeks by intravenous infusion over 60 min, and irinotecan was administered at a dose of 100-180 mg/m2 every 2 weeks by intravenous infusion over 90 min, depending on the preceding treatment dose. To prevent skin toxicities, a moisturizer was applied and oral antibiotics (100 mg minocycline twice daily) were initiated for 6 weeks. The primary endpoint was the response rate (RR) determined by independent reviewers. Secondary endpoints were the disease control rate (DCR), progression-free survival (PFS) time, overall survival (OS) time and adverse events. A total of 35 patients were enrolled between October 2010 and March 2012. The median age was 61 years (range, 41-76 years), with 25 male and 10 female patients. The initial irinotecan dose was 150 mg/m2 in 19 patients and 180 mg/m2 in 1 patient. The remaining patients were treated with ≤120 mg/m2. A central review indicated a partial response in 8 patients (22.9%) and stable disease in 6 patients (17.1%), with an RR of 22.9% (95% confidence interval, 12.1-39.0) and a DCR of 40%. The RR of the patients with standard-dose irinotecan (150 or 180 mg/m2) was 30%, although that of low-dose irinotecan (100-120 mg/m2) was 13%. The median PFS time was 2.7 months, and the median OS time was 6.3 months. A grade 3 or above acne-like rash developed in 25.7% of patients. In conclusion, panitumumab and irinotecan as salvage therapy for mCRC KRAS wild-type patients with skin toxicity prevention exhibits limited efficacy. In particular, the effect of low-dose irinotecan with panitumumab appears to be clinically insignificant. Routine use of skin toxicity prevention is currently under evaluation.
Collapse
Affiliation(s)
- Tomohiro Nishi
- Kawasaki Municipal Ida Hospital, Kawasaki Comprehensive Care Center, Kawasaki, Kanagawa 211-0012, Japan; Department of Medical Oncology, Tochigi Cancer Center, Utsunomiya, Tochigi 320-0834, Japan
| | - Yasuo Hamamoto
- Department of Medical Oncology, Tochigi Cancer Center, Utsunomiya, Tochigi 320-0834, Japan; Keio Cancer Center, Keio University Hospital, School of Medicine, Tokyo 160-8582, Japan
| | - Michitaka Nagase
- Department of Clinical Oncology, Jichi Medical University Hospital, Shimotsuke, Tochigi 329-0498, Japan; Department of Chemotherapy, Japanese Red Cross Nagoya Daiichi Hospital, Nagoya, Aichi 453-8511, Japan
| | - Tadamichi Denda
- Division of Gastroenterology, Chiba Cancer Center, Chiba 260-8717, Japan
| | - Kensei Yamaguchi
- Division of Gastroenterology, Saitama Cancer Center, Saitama 362-0806, Japan
| | - Kenji Amagai
- Department of Gastroenterology, Ibaraki Central Hospital, Kasama, Ibaraki 309-1793, Japan
| | - Yoshinori Miyata
- Department of Medical Oncology, Saku Central Hospital, Saku, Nagano 384-0301, Japan
| | - Yasuhiro Yamanaka
- Department of Medical Oncology, Tochigi Cancer Center, Utsunomiya, Tochigi 320-0834, Japan
| | - Kai Yanai
- Department of Clinical Oncology, Jichi Medical University Hospital, Shimotsuke, Tochigi 329-0498, Japan
| | - Tsutomu Ishikawa
- Department of Diagnostic Radiology, Dokkyo Medical University, Tochigi 321-0293, Japan
| | - Yoshifumi Kuroki
- Department of Diagnostic Imaging, Fukuoka University, Fukuoka 815-0032, Japan
| | - Hirofumi Fujii
- Department of Clinical Oncology, Jichi Medical University Hospital, Shimotsuke, Tochigi 329-0498, Japan
| |
Collapse
|
38
|
Hamano J, Yamaguchi T, Maeda I, Suga A, Hisanaga T, Ishihara T, Iwashita T, Kaneishi K, Kawagoe S, Kuriyama T, Maeda T, Mori I, Nakajima N, Nishi T, Sakurai H, Shimoyama S, Shinjo T, Shirayama H, Yamada T, Morita T. Multicenter cohort study on the survival time of cancer patients dying at home or in a hospital: Does place matter? Cancer 2016; 122:1453-60. [DOI: 10.1002/cncr.29844] [Citation(s) in RCA: 22] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/22/2015] [Revised: 11/23/2015] [Accepted: 11/24/2015] [Indexed: 11/07/2022]
Affiliation(s)
- Jun Hamano
- Division of Clinical Medicine, Faculty of Medicine; University of Tsukuba; Tsukuba Japan
| | - Takashi Yamaguchi
- Department of Palliative Medicine; Kobe University Graduate School of Medicine; Kobe Japan
| | - Isseki Maeda
- Department of Palliative Medicine, Graduate School of Medicine; Osaka University; Suita Japan
| | - Akihiko Suga
- Department of Palliative Medicine; Shizuoka Saiseikai General Hospital; Suruga Japan
| | | | - Tatsuhiko Ishihara
- Palliative Care Department; Okayama Saiseikai General Hospital; Okayama City Japan
| | | | - Keisuke Kaneishi
- Department of Palliative Care Unit; Japan Community Health Care Organization (JCHO) Tokyo Shinjuku Medical Center; Tokyo Japan
| | | | - Toshiyuki Kuriyama
- Department of Palliative Medicine; Wakayama Medical University Hospital Oncology Center; Wakayama Japan
| | - Takashi Maeda
- Department of Palliative Care; Tokyo Metropolitan Cancer and Infectious Disease Center, Komagome Hospital; Tokyo Japan
| | | | - Nobuhisa Nakajima
- Department of Palliative Medicine, Graduate School of Medicine; Tohoku University; Sendai Japan
| | - Tomohiro Nishi
- Kawasaki Comprehensive Care Center; Kawasaki Municipal Ida Hospital; Kawasaki Japan
| | - Hiroki Sakurai
- Palliative Care Team; Cancer Institute Hospital; Tokyo Japan
| | - Satofumi Shimoyama
- Department of Palliative Care; Aichi Cancer Center Hospital; Nagoya Japan
| | | | - Hiroto Shirayama
- Iryouhoujinn Takumikai Osaka Kita Homecare Clinic; Osaka City Japan
| | - Takeshi Yamada
- Department of Gastrointestinal and Hepato-Biliary-Pancreatic Surgery; Nippon Medical School; Tokyo Japan
| | - Tatsuya Morita
- Palliative and Supportive Care Division; Seirei Mikatahara General Hospital; Hamamatsu-Shi Japan
| |
Collapse
|
39
|
Nakayama T, Yasojima H, Morimoto T, Yoshidome K, Mizutani M, Takashima T, Matsunami N, Enami A, Kagawa M, Nomura T, Shiba E, Nishi T, Kamigaki S, Kozuma Y, Yoshinami T, Masuda N. Abstract P1-10-26: Frozen glove could be a new hope for prevention of chemotherapy induced peripheral neuropathy. Cancer Res 2016. [DOI: 10.1158/1538-7445.sabcs15-p1-10-26] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Introduction
Chemotherapy induced peripheral neuropathy (CIPN) is a major problem for patients who receive chemotherapy, and it sometimes deteriorate patients' QOL. Many CIPN prevention trials have been conducted, but no one succeeded to date.
Objectives
To investigate if frozen glove (FG) prevents peripheral neuropathy induced by nanoparticle albumin-bound paclitaxel (nab-PTX).
Methods
We conducted CIPN prevention study using FG, as part of multi-institutional phase II study which analyze efficacy and safety of nab-PTX (260mg/m2 q3w) followed by FEC (500/100/500 mg/m2, q3w) in pre-operative setting (KBCSG-TR 1213 trial). Each patient wore an FGs for a total of 60 minutes (15mins before and after nab-PTX treatment) on both hands. CIPN were assessed during treatment period with nab-PTX by the Patient Neurotoxicity Questionnaire (PNQ) and the FACT/GOG (Gynecologic Oncology Group) Neurotoxicity (Ntx) subscale. Patients were asked to access PNQ and FACT/GOG Ntx on a daily basis and recorded in the CIPN diary.
Results
Sixty two patients were registered for KBCSG-TR 1213 trial. And forty two pts (68%) who turned in the diary were analyzed. Median age and median body mass index (BMI) was 48 years old and 21.6 kg/m2, respectively. We analyzed following 6 categories, 1) symptoms of hands and arms, 2) symptoms of foots, 3) symptoms of general, 4) symptoms of ears 5) muscle weakness of hands and arms and 6) muscle weakness of foots. Median time to each event was 1) 25.5 days, 2) 5days, 3) 3days, 4) not available, 5) 46.5days, 6)4 days. By using FG, time to event of hands and arms was much longer compared with that of foots.
Conclusions
CIPN could be prevented or lessened by FG. Randomized phase II CIPN prevention study has been just launched.
Citation Format: Nakayama T, Yasojima H, Morimoto T, Yoshidome K, Mizutani M, Takashima T, Matsunami N, Enami A, Kagawa M, Nomura T, Shiba E, Nishi T, Kamigaki S, Kozuma Y, Yoshinami T, Masuda N. Frozen glove could be a new hope for prevention of chemotherapy induced peripheral neuropathy. [abstract]. In: Proceedings of the Thirty-Eighth Annual CTRC-AACR San Antonio Breast Cancer Symposium: 2015 Dec 8-12; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2016;76(4 Suppl):Abstract nr P1-10-26.
Collapse
Affiliation(s)
- T Nakayama
- Osaka Medical Center for Cancer and Cardiovascular Disease, Osaka, Japan; NHO Osaka National Hospital, Osaka, Japan; Yao Municipal Hospital, Yao, Osaka, Japan; Osaka Police Hospital, Osaka, Japan; Osaka City University Graduate School of Medicine, Osaka, Japan; Osaka Rosai Hospital, Sakai, Osaka, Japan; Osaka Breast Clinic, Osaka, Japan; Kaizuka City Hospital, Kaizuka, Osaka, Japan; Sakai City Hospital, Sakai, Osaka, Japan; Higashiosaka City Genaral Hospital, Higashiosaka, Osaka, Japan
| | - H Yasojima
- Osaka Medical Center for Cancer and Cardiovascular Disease, Osaka, Japan; NHO Osaka National Hospital, Osaka, Japan; Yao Municipal Hospital, Yao, Osaka, Japan; Osaka Police Hospital, Osaka, Japan; Osaka City University Graduate School of Medicine, Osaka, Japan; Osaka Rosai Hospital, Sakai, Osaka, Japan; Osaka Breast Clinic, Osaka, Japan; Kaizuka City Hospital, Kaizuka, Osaka, Japan; Sakai City Hospital, Sakai, Osaka, Japan; Higashiosaka City Genaral Hospital, Higashiosaka, Osaka, Japan
| | - T Morimoto
- Osaka Medical Center for Cancer and Cardiovascular Disease, Osaka, Japan; NHO Osaka National Hospital, Osaka, Japan; Yao Municipal Hospital, Yao, Osaka, Japan; Osaka Police Hospital, Osaka, Japan; Osaka City University Graduate School of Medicine, Osaka, Japan; Osaka Rosai Hospital, Sakai, Osaka, Japan; Osaka Breast Clinic, Osaka, Japan; Kaizuka City Hospital, Kaizuka, Osaka, Japan; Sakai City Hospital, Sakai, Osaka, Japan; Higashiosaka City Genaral Hospital, Higashiosaka, Osaka, Japan
| | - K Yoshidome
- Osaka Medical Center for Cancer and Cardiovascular Disease, Osaka, Japan; NHO Osaka National Hospital, Osaka, Japan; Yao Municipal Hospital, Yao, Osaka, Japan; Osaka Police Hospital, Osaka, Japan; Osaka City University Graduate School of Medicine, Osaka, Japan; Osaka Rosai Hospital, Sakai, Osaka, Japan; Osaka Breast Clinic, Osaka, Japan; Kaizuka City Hospital, Kaizuka, Osaka, Japan; Sakai City Hospital, Sakai, Osaka, Japan; Higashiosaka City Genaral Hospital, Higashiosaka, Osaka, Japan
| | - M Mizutani
- Osaka Medical Center for Cancer and Cardiovascular Disease, Osaka, Japan; NHO Osaka National Hospital, Osaka, Japan; Yao Municipal Hospital, Yao, Osaka, Japan; Osaka Police Hospital, Osaka, Japan; Osaka City University Graduate School of Medicine, Osaka, Japan; Osaka Rosai Hospital, Sakai, Osaka, Japan; Osaka Breast Clinic, Osaka, Japan; Kaizuka City Hospital, Kaizuka, Osaka, Japan; Sakai City Hospital, Sakai, Osaka, Japan; Higashiosaka City Genaral Hospital, Higashiosaka, Osaka, Japan
| | - T Takashima
- Osaka Medical Center for Cancer and Cardiovascular Disease, Osaka, Japan; NHO Osaka National Hospital, Osaka, Japan; Yao Municipal Hospital, Yao, Osaka, Japan; Osaka Police Hospital, Osaka, Japan; Osaka City University Graduate School of Medicine, Osaka, Japan; Osaka Rosai Hospital, Sakai, Osaka, Japan; Osaka Breast Clinic, Osaka, Japan; Kaizuka City Hospital, Kaizuka, Osaka, Japan; Sakai City Hospital, Sakai, Osaka, Japan; Higashiosaka City Genaral Hospital, Higashiosaka, Osaka, Japan
| | - N Matsunami
- Osaka Medical Center for Cancer and Cardiovascular Disease, Osaka, Japan; NHO Osaka National Hospital, Osaka, Japan; Yao Municipal Hospital, Yao, Osaka, Japan; Osaka Police Hospital, Osaka, Japan; Osaka City University Graduate School of Medicine, Osaka, Japan; Osaka Rosai Hospital, Sakai, Osaka, Japan; Osaka Breast Clinic, Osaka, Japan; Kaizuka City Hospital, Kaizuka, Osaka, Japan; Sakai City Hospital, Sakai, Osaka, Japan; Higashiosaka City Genaral Hospital, Higashiosaka, Osaka, Japan
| | - A Enami
- Osaka Medical Center for Cancer and Cardiovascular Disease, Osaka, Japan; NHO Osaka National Hospital, Osaka, Japan; Yao Municipal Hospital, Yao, Osaka, Japan; Osaka Police Hospital, Osaka, Japan; Osaka City University Graduate School of Medicine, Osaka, Japan; Osaka Rosai Hospital, Sakai, Osaka, Japan; Osaka Breast Clinic, Osaka, Japan; Kaizuka City Hospital, Kaizuka, Osaka, Japan; Sakai City Hospital, Sakai, Osaka, Japan; Higashiosaka City Genaral Hospital, Higashiosaka, Osaka, Japan
| | - M Kagawa
- Osaka Medical Center for Cancer and Cardiovascular Disease, Osaka, Japan; NHO Osaka National Hospital, Osaka, Japan; Yao Municipal Hospital, Yao, Osaka, Japan; Osaka Police Hospital, Osaka, Japan; Osaka City University Graduate School of Medicine, Osaka, Japan; Osaka Rosai Hospital, Sakai, Osaka, Japan; Osaka Breast Clinic, Osaka, Japan; Kaizuka City Hospital, Kaizuka, Osaka, Japan; Sakai City Hospital, Sakai, Osaka, Japan; Higashiosaka City Genaral Hospital, Higashiosaka, Osaka, Japan
| | - T Nomura
- Osaka Medical Center for Cancer and Cardiovascular Disease, Osaka, Japan; NHO Osaka National Hospital, Osaka, Japan; Yao Municipal Hospital, Yao, Osaka, Japan; Osaka Police Hospital, Osaka, Japan; Osaka City University Graduate School of Medicine, Osaka, Japan; Osaka Rosai Hospital, Sakai, Osaka, Japan; Osaka Breast Clinic, Osaka, Japan; Kaizuka City Hospital, Kaizuka, Osaka, Japan; Sakai City Hospital, Sakai, Osaka, Japan; Higashiosaka City Genaral Hospital, Higashiosaka, Osaka, Japan
| | - E Shiba
- Osaka Medical Center for Cancer and Cardiovascular Disease, Osaka, Japan; NHO Osaka National Hospital, Osaka, Japan; Yao Municipal Hospital, Yao, Osaka, Japan; Osaka Police Hospital, Osaka, Japan; Osaka City University Graduate School of Medicine, Osaka, Japan; Osaka Rosai Hospital, Sakai, Osaka, Japan; Osaka Breast Clinic, Osaka, Japan; Kaizuka City Hospital, Kaizuka, Osaka, Japan; Sakai City Hospital, Sakai, Osaka, Japan; Higashiosaka City Genaral Hospital, Higashiosaka, Osaka, Japan
| | - T Nishi
- Osaka Medical Center for Cancer and Cardiovascular Disease, Osaka, Japan; NHO Osaka National Hospital, Osaka, Japan; Yao Municipal Hospital, Yao, Osaka, Japan; Osaka Police Hospital, Osaka, Japan; Osaka City University Graduate School of Medicine, Osaka, Japan; Osaka Rosai Hospital, Sakai, Osaka, Japan; Osaka Breast Clinic, Osaka, Japan; Kaizuka City Hospital, Kaizuka, Osaka, Japan; Sakai City Hospital, Sakai, Osaka, Japan; Higashiosaka City Genaral Hospital, Higashiosaka, Osaka, Japan
| | - S Kamigaki
- Osaka Medical Center for Cancer and Cardiovascular Disease, Osaka, Japan; NHO Osaka National Hospital, Osaka, Japan; Yao Municipal Hospital, Yao, Osaka, Japan; Osaka Police Hospital, Osaka, Japan; Osaka City University Graduate School of Medicine, Osaka, Japan; Osaka Rosai Hospital, Sakai, Osaka, Japan; Osaka Breast Clinic, Osaka, Japan; Kaizuka City Hospital, Kaizuka, Osaka, Japan; Sakai City Hospital, Sakai, Osaka, Japan; Higashiosaka City Genaral Hospital, Higashiosaka, Osaka, Japan
| | - Y Kozuma
- Osaka Medical Center for Cancer and Cardiovascular Disease, Osaka, Japan; NHO Osaka National Hospital, Osaka, Japan; Yao Municipal Hospital, Yao, Osaka, Japan; Osaka Police Hospital, Osaka, Japan; Osaka City University Graduate School of Medicine, Osaka, Japan; Osaka Rosai Hospital, Sakai, Osaka, Japan; Osaka Breast Clinic, Osaka, Japan; Kaizuka City Hospital, Kaizuka, Osaka, Japan; Sakai City Hospital, Sakai, Osaka, Japan; Higashiosaka City Genaral Hospital, Higashiosaka, Osaka, Japan
| | - T Yoshinami
- Osaka Medical Center for Cancer and Cardiovascular Disease, Osaka, Japan; NHO Osaka National Hospital, Osaka, Japan; Yao Municipal Hospital, Yao, Osaka, Japan; Osaka Police Hospital, Osaka, Japan; Osaka City University Graduate School of Medicine, Osaka, Japan; Osaka Rosai Hospital, Sakai, Osaka, Japan; Osaka Breast Clinic, Osaka, Japan; Kaizuka City Hospital, Kaizuka, Osaka, Japan; Sakai City Hospital, Sakai, Osaka, Japan; Higashiosaka City Genaral Hospital, Higashiosaka, Osaka, Japan
| | - N Masuda
- Osaka Medical Center for Cancer and Cardiovascular Disease, Osaka, Japan; NHO Osaka National Hospital, Osaka, Japan; Yao Municipal Hospital, Yao, Osaka, Japan; Osaka Police Hospital, Osaka, Japan; Osaka City University Graduate School of Medicine, Osaka, Japan; Osaka Rosai Hospital, Sakai, Osaka, Japan; Osaka Breast Clinic, Osaka, Japan; Kaizuka City Hospital, Kaizuka, Osaka, Japan; Sakai City Hospital, Sakai, Osaka, Japan; Higashiosaka City Genaral Hospital, Higashiosaka, Osaka, Japan
| |
Collapse
|
40
|
Kisamori K, Shimoura S, Miya H, Michimasa S, Ota S, Assie M, Baba H, Baba T, Beaumel D, Dozono M, Fujii T, Fukuda N, Go S, Hammache F, Ideguchi E, Inabe N, Itoh M, Kameda D, Kawase S, Kawabata T, Kobayashi M, Kondo Y, Kubo T, Kubota Y, Kurata-Nishimura M, Lee CS, Maeda Y, Matsubara H, Miki K, Nishi T, Noji S, Sakaguchi S, Sakai H, Sasamoto Y, Sasano M, Sato H, Shimizu Y, Stolz A, Suzuki H, Takaki M, Takeda H, Takeuchi S, Tamii A, Tang L, Tokieda H, Tsumura M, Uesaka T, Yako K, Yanagisawa Y, Yokoyama R, Yoshida K. Candidate Resonant Tetraneutron State Populated by the ^{4}He(^{8}He,^{8}Be) Reaction. Phys Rev Lett 2016; 116:052501. [PMID: 26894705 DOI: 10.1103/physrevlett.116.052501] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/30/2015] [Indexed: 06/05/2023]
Abstract
A candidate resonant tetraneutron state is found in the missing-mass spectrum obtained in the double-charge-exchange reaction ^{4}He(^{8}He,^{8}Be) at 186 MeV/u. The energy of the state is 0.83±0.65(stat)±1.25(syst) MeV above the threshold of four-neutron decay with a significance level of 4.9σ. Utilizing the large positive Q value of the (^{8}He,^{8}Be) reaction, an almost recoilless condition of the four-neutron system was achieved so as to obtain a weakly interacting four-neutron system efficiently.
Collapse
Affiliation(s)
- K Kisamori
- Center for Nuclear Study, The University of Tokyo, 7-3-1 Hongo, Bunkyo, Tokyo 113-0033, Japan
- RIKEN Nishina Center, 2-1 Hirosawa, Wako, Saitama 351-0198, Japan
| | - S Shimoura
- Center for Nuclear Study, The University of Tokyo, 7-3-1 Hongo, Bunkyo, Tokyo 113-0033, Japan
| | - H Miya
- Center for Nuclear Study, The University of Tokyo, 7-3-1 Hongo, Bunkyo, Tokyo 113-0033, Japan
- RIKEN Nishina Center, 2-1 Hirosawa, Wako, Saitama 351-0198, Japan
| | - S Michimasa
- Center for Nuclear Study, The University of Tokyo, 7-3-1 Hongo, Bunkyo, Tokyo 113-0033, Japan
| | - S Ota
- Center for Nuclear Study, The University of Tokyo, 7-3-1 Hongo, Bunkyo, Tokyo 113-0033, Japan
| | - M Assie
- IPN Orsay, 15 Rue, Georges, Clemenceau 91400 Orsay, France
| | - H Baba
- RIKEN Nishina Center, 2-1 Hirosawa, Wako, Saitama 351-0198, Japan
| | - T Baba
- Department of Physics, Kyoto University, Yoshida-Honcho, Sakyo, Kyoto 606-8501, Japan
| | - D Beaumel
- RIKEN Nishina Center, 2-1 Hirosawa, Wako, Saitama 351-0198, Japan
- IPN Orsay, 15 Rue, Georges, Clemenceau 91400 Orsay, France
| | - M Dozono
- RIKEN Nishina Center, 2-1 Hirosawa, Wako, Saitama 351-0198, Japan
| | - T Fujii
- Center for Nuclear Study, The University of Tokyo, 7-3-1 Hongo, Bunkyo, Tokyo 113-0033, Japan
- RIKEN Nishina Center, 2-1 Hirosawa, Wako, Saitama 351-0198, Japan
| | - N Fukuda
- RIKEN Nishina Center, 2-1 Hirosawa, Wako, Saitama 351-0198, Japan
| | - S Go
- Center for Nuclear Study, The University of Tokyo, 7-3-1 Hongo, Bunkyo, Tokyo 113-0033, Japan
- RIKEN Nishina Center, 2-1 Hirosawa, Wako, Saitama 351-0198, Japan
| | - F Hammache
- IPN Orsay, 15 Rue, Georges, Clemenceau 91400 Orsay, France
| | - E Ideguchi
- Research Center for Nuclear Physics, Osaka University, 10-1 Mihogaoka, Ibaraki, Osaka 567-0047, Japan
| | - N Inabe
- RIKEN Nishina Center, 2-1 Hirosawa, Wako, Saitama 351-0198, Japan
| | - M Itoh
- Cyclotron and Radioisotope Center, Tohoku University, 6-3 Aoba, Aramaki, Aoba-ku, Sendai, Miyagi 980-8578, Japan
| | - D Kameda
- RIKEN Nishina Center, 2-1 Hirosawa, Wako, Saitama 351-0198, Japan
| | - S Kawase
- Center for Nuclear Study, The University of Tokyo, 7-3-1 Hongo, Bunkyo, Tokyo 113-0033, Japan
| | - T Kawabata
- Department of Physics, Kyoto University, Yoshida-Honcho, Sakyo, Kyoto 606-8501, Japan
| | - M Kobayashi
- Center for Nuclear Study, The University of Tokyo, 7-3-1 Hongo, Bunkyo, Tokyo 113-0033, Japan
| | - Y Kondo
- RIKEN Nishina Center, 2-1 Hirosawa, Wako, Saitama 351-0198, Japan
- Department of Physics, Tokyo Institute of Technology, 2-12-1 O-Okayama, Meguro, Tokyo 152-8550, Japan
| | - T Kubo
- RIKEN Nishina Center, 2-1 Hirosawa, Wako, Saitama 351-0198, Japan
| | - Y Kubota
- Center for Nuclear Study, The University of Tokyo, 7-3-1 Hongo, Bunkyo, Tokyo 113-0033, Japan
- RIKEN Nishina Center, 2-1 Hirosawa, Wako, Saitama 351-0198, Japan
| | | | - C S Lee
- Center for Nuclear Study, The University of Tokyo, 7-3-1 Hongo, Bunkyo, Tokyo 113-0033, Japan
- RIKEN Nishina Center, 2-1 Hirosawa, Wako, Saitama 351-0198, Japan
| | - Y Maeda
- Faculty of Engineering, University of Miyazaki, 1-1 Gakuen, Kibanadai-nishi, Miyazaki 889-2192, Japan
| | - H Matsubara
- National Institute of Radiological Sciences, 4-9-1 Anagawa, Inage, Chiba, Japan
| | - K Miki
- Research Center for Nuclear Physics, Osaka University, 10-1 Mihogaoka, Ibaraki, Osaka 567-0047, Japan
| | - T Nishi
- RIKEN Nishina Center, 2-1 Hirosawa, Wako, Saitama 351-0198, Japan
- Department of Physics, The University of Tokyo, 7-3-1 Hongo, Bunkyo, Tokyo 113-0033, Japan
| | - S Noji
- National Superconducting Cyclotron Laboratory, Michigan State University, 640 S Shaw Lane, East Lansing, Michigan 48824, USA
| | - S Sakaguchi
- RIKEN Nishina Center, 2-1 Hirosawa, Wako, Saitama 351-0198, Japan
- Department of Physics, Kyushu University, 6-10-1 Hakozaki, Higashi, Fukuoka 812-8581, Japan
| | - H Sakai
- RIKEN Nishina Center, 2-1 Hirosawa, Wako, Saitama 351-0198, Japan
| | - Y Sasamoto
- Center for Nuclear Study, The University of Tokyo, 7-3-1 Hongo, Bunkyo, Tokyo 113-0033, Japan
| | - M Sasano
- RIKEN Nishina Center, 2-1 Hirosawa, Wako, Saitama 351-0198, Japan
| | - H Sato
- RIKEN Nishina Center, 2-1 Hirosawa, Wako, Saitama 351-0198, Japan
| | - Y Shimizu
- RIKEN Nishina Center, 2-1 Hirosawa, Wako, Saitama 351-0198, Japan
| | - A Stolz
- National Superconducting Cyclotron Laboratory, Michigan State University, 640 S Shaw Lane, East Lansing, Michigan 48824, USA
| | - H Suzuki
- RIKEN Nishina Center, 2-1 Hirosawa, Wako, Saitama 351-0198, Japan
| | - M Takaki
- Center for Nuclear Study, The University of Tokyo, 7-3-1 Hongo, Bunkyo, Tokyo 113-0033, Japan
| | - H Takeda
- RIKEN Nishina Center, 2-1 Hirosawa, Wako, Saitama 351-0198, Japan
| | - S Takeuchi
- RIKEN Nishina Center, 2-1 Hirosawa, Wako, Saitama 351-0198, Japan
| | - A Tamii
- Research Center for Nuclear Physics, Osaka University, 10-1 Mihogaoka, Ibaraki, Osaka 567-0047, Japan
| | - L Tang
- Center for Nuclear Study, The University of Tokyo, 7-3-1 Hongo, Bunkyo, Tokyo 113-0033, Japan
| | - H Tokieda
- Center for Nuclear Study, The University of Tokyo, 7-3-1 Hongo, Bunkyo, Tokyo 113-0033, Japan
| | - M Tsumura
- Department of Physics, Kyoto University, Yoshida-Honcho, Sakyo, Kyoto 606-8501, Japan
| | - T Uesaka
- RIKEN Nishina Center, 2-1 Hirosawa, Wako, Saitama 351-0198, Japan
| | - K Yako
- Center for Nuclear Study, The University of Tokyo, 7-3-1 Hongo, Bunkyo, Tokyo 113-0033, Japan
| | - Y Yanagisawa
- RIKEN Nishina Center, 2-1 Hirosawa, Wako, Saitama 351-0198, Japan
| | - R Yokoyama
- Center for Nuclear Study, The University of Tokyo, 7-3-1 Hongo, Bunkyo, Tokyo 113-0033, Japan
| | - K Yoshida
- RIKEN Nishina Center, 2-1 Hirosawa, Wako, Saitama 351-0198, Japan
| |
Collapse
|
41
|
Ogura Y, Yuki N, Sukegane A, Nishi T, Miyake Y, Sato H, Miyamoto C, Mihara C. Treatment of pressure ulcers in patients with declining renal function using arginine, glutamine and ß-hydroxy-ß-methylbutyrate. J Wound Care 2016; 24:478-82. [PMID: 26488739 DOI: 10.12968/jowc.2015.24.10.478] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Abstract
The aim of this study is to examine the efficacy on healing pressure ulcers (PU) of using a supplement combination containing arginine, glutamine and ß-hydroxy-ß-methylbutyrate, which was given to two elderly patients with renal dysfunction. The PU was surgically opened, decompressed and treated by drugs. A half quantity of the defined dose of the supplement combination, with an enteral nutrition product, was administered to the patients twice a day. This combination improved the PUs, with no effect on renal function. This novel finding may provide a nutritional rationale of arginine, glutamine and ß-hydroxy-ß-methylbutyrate for PUs associated with renal dysfunction.
Collapse
Affiliation(s)
- Y Ogura
- Assistant Professor, Professor, Department of Nutritional Sciences Faculty of Human Ecology, Yasuda Women's University, Hiroshima, Japan
| | - N Yuki
- Certified Nutrition Support Team Dietitian of JSPEN, Registered Dietitian, Department of Nutrition, Hibino Hospital, Hiroshima, Japan
| | - A Sukegane
- Certified Nutrition Support Team Occupational Therapist of JSPEN, Department of Rehabilitation, Hibino Hospital, Hiroshima, Japan
| | - T Nishi
- Pharmacist, Certified Nutrition Support Team Nurse, Department of Nursing, Hibino Hospital, Hiroshima, Japan
| | - Y Miyake
- Department of Pharmacy, Hibino Hospital, Hiroshima, Japan
| | - H Sato
- Department of Neurosurgery, Hibino Hospital, Hiroshima, Japan
| | - C Miyamoto
- Nurse, Department of Nursing, Sin-ai nursing home, Hiroshima, Japan
| | - C Mihara
- Assistant Professor, Professor, Department of Nutritional Sciences Faculty of Human Ecology, Yasuda Women's University, Hiroshima, Japan
| |
Collapse
|
42
|
Baba M, Maeda I, Morita T, Hisanaga T, Ishihara T, Iwashita T, Kaneishi K, Kawagoe S, Kuriyama T, Maeda T, Mori I, Nakajima N, Nishi T, Sakurai H, Shimoyama S, Shinjo T, Shirayama H, Yamada T, Ono S, Ozawa T, Yamamoto R, Tsuneto S. Independent validation of the modified prognosis palliative care study predictor models in three palliative care settings. J Pain Symptom Manage 2015; 49:853-60. [PMID: 25499420 DOI: 10.1016/j.jpainsymman.2014.10.010] [Citation(s) in RCA: 31] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/21/2014] [Revised: 10/02/2014] [Accepted: 10/22/2014] [Indexed: 11/22/2022]
Abstract
CONTEXT Accurate prognostic information in palliative care settings is needed for patients to make decisions and set goals and priorities. The Prognosis Palliative Care Study (PiPS) predictor models were presented in 2011, but have not yet been fully validated by other research teams. OBJECTIVES The primary aim of this study is to examine the accuracy and to validate the modified PiPS (using physician-proxy ratings of mental status instead of patient interviews) in three palliative care settings, namely palliative care units, hospital-based palliative care teams, and home-based palliative care services. METHODS This multicenter prospective cohort study was conducted in 58 palliative care services including 16 palliative care units, 19 hospital-based palliative care teams, and 23 home-based palliative care services in Japan from September 2012 through April 2014. RESULTS A total of 2426 subjects were recruited. For reasons including lack of followup and missing variables (primarily blood examination data), we obtained analyzable data from 2212 and 1257 patients for the modified PiPS-A and PiPS-B, respectively. In all palliative care settings, both the modified PiPS-A and PiPS-B identified three risk groups with different survival rates (P<0.001). The absolute agreement ranged from 56% to 60% in the PiPS-A model and 60% to 62% in the PiPS-B model. CONCLUSION The modified PiPS was successfully validated and can be useful in palliative care units, hospital-based palliative care teams, and home-based palliative care services.
Collapse
Affiliation(s)
- Mika Baba
- Department of Palliative Care, Saito Yukoukai Hospital, Ibaragi, Osaka, Japan.
| | - Isseki Maeda
- Department of Palliative Medicine, Graduate School of Medicine, Osaka University, Suita, Osaka, Japan
| | - Tatsuya Morita
- Palliative and Supportive Care Division, Seirei Mikatahara General Hospital, Hamamatsu City, Shizuoka, Japan
| | | | - Tatsuhiko Ishihara
- Palliative Care Department, Okayama Saiseikai General Hospital, Okayama City, Okayama, Japan
| | | | - Keisuke Kaneishi
- Department of Palliative Care Unit, JCHO Tokyo Shinjuku Medical Center, Shinjuku, Tokyo, Japan
| | | | - Toshiyuki Kuriyama
- Department of Palliative Medicine, Wakayama Medical University Hospital Oncology Center, Kimiidera, Wakayama, Japan
| | - Takashi Maeda
- Department of Palliative Care, Tokyo Metropolitan Cancer and Infectious Disease Center, Komagome Hospital, Bunkyo-ku, Tokyo, Japan
| | | | - Nobuhisa Nakajima
- Department of Palliative Medicine, Graduate School of Medicine, Tohoku University, Sendai, Miyagi, Japan
| | - Tomohiro Nishi
- Kawasaki Comprehensive Care Center, Kawasaki Municipal Ida Hospital, Nakahara-ku, Kanagawa, Japan
| | - Hiroki Sakurai
- Department of Palliative Care, St. Luke's International Hospital, Chuo-ku, Tokyo, Japan
| | - Satofumi Shimoyama
- Department of Palliative Care, Aichi Cancer Center Hospital, Chikusa-ku, Nagoya, Japan
| | | | - Hiroto Shirayama
- Iryouhoujinn Takumikai Osaka Kita Homecare Clinic, Osaka City, Osaka, Japan
| | - Takeshi Yamada
- Department of Gastrointestinal and Hepatobiliary-Pancreatic Surgery, Nippon Medical School, Bunkyo-ku, Tokyo, Japan
| | - Shigeki Ono
- Division of Palliative Medicine, Shizuoka Cancer Center Hospital, Suntou-gun, Shizuoka, Japan
| | | | - Ryo Yamamoto
- Department of Palliative Medicine, Saku Central Hospital Advanced Care Center, Saku-shi, Nagano, Japan
| | - Satoru Tsuneto
- Department of Multidisciplinary Cancer Treatment, Graduate School of Medicine, Kyoto University, Sakyo-ku, Kyoto, Japan
| |
Collapse
|
43
|
Kawaida Y, Fukudome K, Uejima A, Nishi T, Hata K, Taniyama S, Oowatashi A, Yone K. Virtual reality training for fall prevention. Physiotherapy 2015. [DOI: 10.1016/j.physio.2015.03.3593] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
44
|
Hata K, Kiyama R, Ishido Y, Yone K, Fukudome K, Nishi T, Kawaida Y. Estimation of hip joint loading during gait before and after total hip arthroplasty using a musculoskeletal modeling system. Physiotherapy 2015. [DOI: 10.1016/j.physio.2015.03.3358] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
45
|
Nishi T, Fukudome K, Yone K, Maeda T, Hata K, Kawaida Y. Evaluation of active upper limb ability in cervical spondylotic myelopathy via an artificial neural network. Physiotherapy 2015. [DOI: 10.1016/j.physio.2015.03.1990] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
46
|
Miura T, Matsumoto Y, Hama T, Amano K, Tei Y, Kikuchi A, Suga A, Hisanaga T, Ishihara T, Abe M, Kaneishi K, Kawagoe S, Kuriyama T, Maeda T, Mori I, Nakajima N, Nishi T, Sakurai H, Morita T, Kinoshita H. Glasgow prognostic score predicts prognosis for cancer patients in palliative settings: a subanalysis of the Japan-prognostic assessment tools validation (J-ProVal) study. Support Care Cancer 2015; 23:3149-56. [PMID: 25777319 DOI: 10.1007/s00520-015-2693-x] [Citation(s) in RCA: 22] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/11/2014] [Accepted: 03/02/2015] [Indexed: 01/04/2023]
Abstract
PURPOSE The Glasgow prognostic score (GPS), which uses C-reactive protein and albumin levels, is a good predictor of prognosis in cancer patients undergoing anti-tumor therapy. The objective of this study was to investigate the correlation between GPS and survival among cancer patients in palliative settings, as findings in such populations have not been well described. METHODS This was a subanalysis of a multicenter, prospective, cohort study in patients who were adults, diagnosed with advanced cancer, and first referred to palliative care service in Japan. Patients who were not receiving anti-tumor therapy and who had undergone laboratory examinations were eligible. Clinical features were analyzed to investigate prognostic factors. RESULTS A total of 1160 patients were enrolled (41.6 % female; median age, 72 years). The independent predictors were Eastern Cooperative Oncology Group performance status (ECOG PS) score of 4 (hazard ratio (HR), 1.54), liver metastasis (HR, 1.21), dyspnea (HR, 1.35), edema (HR, 1.25), prognostic performance index (HR, 1.56), neutrophil-lymphocyte ratio (HR, 1.43), and GPS of 2 (HR, 1.36). The sensitivity and specificity for 3-week prognosis of a GPS of 2 were 0.879 and 0.410. Median survival time with GPS of 0, 1, and 2 was 58 days (95 % confidence interval, 48-81), 43 days (37-50), and 21 days (19-24), respectively (log-rank test, p < 0.001). CONCLUSION The GPS was a good prognostic indicator for cancer patients in palliative settings.
Collapse
Affiliation(s)
- Tomofumi Miura
- Department of Palliative Medicine, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa, Chiba, 277-8577, Japan.
| | - Yoshihisa Matsumoto
- Department of Palliative Medicine, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa, Chiba, 277-8577, Japan.
| | - Takashi Hama
- Osaka Medical Center for Cancer and Cardiovascular Diseases, 1-3-3 Nakamichi, Higashinari-ku, Osaka, 537-8511, Japan.
| | - Koji Amano
- Department of Palliative Medicine,, Osaka City General Hospital, 2-13-22 Miyakojima-hondori, Miyakojima-ku, Osaka, 534-0021, Japan.
| | - Yo Tei
- Seirei Hospice, Seirei Mikatahara General Hospital, 3453 Mikatahara-cho, Kita-ku, Hamamatsu City, Shizuoka, 433-8558, Japan.
| | - Ayako Kikuchi
- Department of Oncology, Mitsubishi Kyoto Hospital, Goshocho 1 Katsura, Nishikyoku, Kyoto, 615-8087, Japan.
| | - Akihiko Suga
- Department of Palliative Medicine, Shizuoka Saiseikai General Hospital, 1-1-1 Oshika, Suruga, Shizuoka, 422-8527, Japan.
| | - Takayuki Hisanaga
- Tsukuba Medical Center Foundation, 1-3-1 Amakubo, Tsukuba, Ibaraki, 305-8558, Japan.
| | - Tatsuhiko Ishihara
- Palliative Care Department, Okayama Saiseikai General Hospital, 1-17-18 Ifukucho, Kita-ku, Okayama City, Okayama, 700-8511, Japan.
| | - Mutsumi Abe
- Matsue City Hospital, 32-1 Noshira-cho, Matsue City, Shimane, 690-8509, Japan.
| | - Keisuke Kaneishi
- Department of Palliative Care Unit, JCHO Tokyo Shinjuku Medical Center, 5-1 Tsukudo-cho, Shinjuku, Tokyo, 162-8543, Japan.
| | - Shohei Kawagoe
- Aozora Clinic, 2-357 Midorigaoka, Matsudo City, Chiba, 271-0074, Japan.
| | - Toshiyuki Kuriyama
- Department of Palliative Medicine, Wakayama Medical University Hospital Oncology Center, 811-1 Kimiidera, Wakayama, 641-8509, Japan.
| | - Takashi Maeda
- Department of Palliative Care, Tokyo Metropolitan Cancer and Infectious Disease Center Komagome Hospital, 3-18-22 Honkomagome, Bunkyo-ku, Tokyo, 113-8677, Japan.
| | - Ichiro Mori
- Gratia Hospital Hospice, 6-14-1 Aomadaninishi, Mino, Osaka, 562-8567, Japan.
| | - Nobuhisa Nakajima
- Department of Palliative Medicine, Graduate School of Medicine, Tohoku University, 1-1 Seiryo-machi, Aobaku, Sendai, Miyagi, 980-8574, Japan.
| | - Tomohiro Nishi
- Kawasaki Comprehensive Care Center, Kawasaki Municipal Ida Hospital, 2-27-1 Ida, Nakahara-ku, Kawasaki, Kanagawa, 211-0035, Japan.
| | - Hiroki Sakurai
- Department of Palliative Care, St. Luke's International Hospital, Tokyo, 9-1 Akashi-cho, Chuo-ku, Tokyo, 104-8560, Japan.
| | - Tatsuya Morita
- Palliative and Supportive Care Division, Seirei Mikatahara General Hospital, 3453 Mikatahara-cho, Kita-ku, Hamamatsu City, Shizuoka, 433-8558, Japan.
| | - Hiroya Kinoshita
- Department of Palliative Medicine, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa, Chiba, 277-8577, Japan.
| |
Collapse
|
47
|
Yoshida T, Oishi K, Nishi T, Ishibashi T. Nd3-xBixFe4GaO12(x = 2, 2.5) films on glass substrates prepared by MOD method. EPJ Web of Conferences 2014. [DOI: 10.1051/epjconf/20147505009] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
48
|
Ito E, Ozawa S, Kijima H, Kazuno A, Miyako H, Nishi T, Chino O, Shimada H, Tanaka M, Inoue S, Inokuchi S, Makuuchi H. Clinicopathological significance of laminin-5γ2 chain expression in superficial esophageal cancer. Dis Esophagus 2014; 27:463-9. [PMID: 22978811 DOI: 10.1111/j.1442-2050.2012.01416.x] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/11/2022]
Abstract
The glycoprotein laminin 5γ2 chain (LN-5γ2) has recently become a focus of increased interest and investigation as a marker of invasion in gastrointestinal malignancies. We investigated the significance of LN-5γ2 expression as a prognostic factor in superficial esophageal cancer. The study population consisted of 87 patients who had undergone a transthoracic esophagectomy and three-field lymphadenectomy for the treatment of superficial esophageal cancer at Tokai University Hospital. Formalin-fixed, paraffin-embedded sections of the resected specimens were examined using immunohistochemical staining and hematoxylin and eosin staining to assess the correlations between the LN-5γ2 expression pattern and the clinicopathological factors (age, sex, T-factor, N-factor, ly-factor, v-factor, degree of differentiation, infiltrative growth pattern, tumor node metastasis classification of malignant tumors [TNM] stage, etc.) and the patient outcome. The expression pattern of LN-5γ2 was classified into an extracellular type (E type), characterized by the staining of extracellular matrix such as the basement membrane and the stroma (31 cases, 35.6%), and a cytoplasmic type (C type), characterized by the staining of the cytoplasm in the cancer cells (56 cases, 64.6%). The expression pattern was not correlated with any of the clinicopathological factors that were assessed. However, univariate analyses of the survival analysis data showed that the N-factor (P = 0.011), TNM stage (P = 0.011), and LN-5γ2 C type (P = 0.017) were prognostic factors. A multivariate analysis revealed that the N-factor (P = 0.049) and LN-5γ2 C type (P = 0.048) were prognostic factors. In the survival analysis, a univariate analysis of the 75 T1b cases also showed that the N-factor (P = 0.048), TNM stage (P = 0.048), and LN-5γ2 C type (P = 0.029) were prognostic factors, while a multivariate analysis showed that the LN-5γ2 C type (P = 0.035) was a prognostic factor. The C type expression of LN-5γ2, i.e. confined to the cytoplasm, was correlated with an unfavorable outcome among the patients with superficial esophageal cancer in the present series. Observation of the LN-5γ2 expression pattern may be useful for the diagnosis of highly malignant tumors.
Collapse
Affiliation(s)
- E Ito
- Department of Gastroenterological Surgery, Tokai University School of Medicine, Isehara, Kanagawa, Japan
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
49
|
Kawabata Y, Nishi T, Tanaka T, Tajima Y. Safety and Feasibility of a Pancreaticoduodenectomy with Total Meso-Pancreatoduodenum Excision: Analysis in Various Periampullary Disorders. Hepatogastroenterology 2014; 61:821-827. [PMID: 26176080] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/04/2023]
Abstract
BACKGROUND/AIMS This study aimed to evaluate the safety and feasibility of a pancreaticoduodenectomy with total meso-pancreatoduodenum excision (tMPDe) as an new anatomical concept. METHODOLOGY A total of 90 patients underwent PD for various periampullary diseases. Of these, 52 patients received a conventional PD (cPD), while 38 patients underwent a tMPDe. Surgical outcomes were compared between the two study groups. RESULTS Operative time was equivalent in the two groups; however, the estimated blood loss (cPD, 1360 ml; tMPDe, 995 ml; median, P = 0.026) and blood transfusion rate (cPD, 63%; tMPDe, 31% ; P = 0.001) were significantly decreased in tMPDe. Morbidity had no significant difference between cPD and tMPDe, and tMPDe showed no characteristic complications. With regard to oncological aspects, tMPDe was superior to cPD. Risk factors analysis revealed the operative time (P = 0.003), estimated blood loss (P < 0.001), and blood transfusion (P < 0.001) to be significant predictive risk factors for postoperative morbidity but not tMPDe procedure (P = 0.794). CONCLUSIONS tMPDe is safe and superior to cPD because it is a bloodless operation with a good oncological outcome: We concluded that tMPDe should be adaptable to various periampullary diseases, including benign and low-grade malignant disorders.
Collapse
|
50
|
Denda T, Nishi T, Yamaguchi K, Kenji A, Miyata Y, Yamanaka Y, Yanai K, Hamamoto Y, Nagase M, Fujii H. A Phase II Study of the Panitumumab+ Irinotecan Therapy for Advanced / Recurrence Colorectal Cancer (Topic Study). Ann Oncol 2013. [DOI: 10.1093/annonc/mdt459.51] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|